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                                          INTRODUCTION
1INTRODUCTION
Clinical  seizures  are  defined  as  paroxysmal  alteration  in  neurological
function  i.e. behavioural,  motor  and/or  autonomic  function. Newborn  period  is  the
time  when  the incidence  of  seizures  is  the   highest,  yet  their  clinical  recognition
is   difficult,    therefore   true   incidence   of   neonatal   seizures   is   difficult   to
determine.1  Its  incidence  varies  from  1-5 per 1000  live births.2-6  Neonatal  seizures
are  very  common  in  the  first  weeks  of  life. Clinical  features  of  neonatal  seizures
are   different   from  those   in   adults.7   Neonatal   seizures   are   distinctive   clinical
manifestation  of  neurological   dysfunction  in  the  newborn.8  Newborn  infants  with
seizures  are  at  risk  for  neonatal  death  and  survivors  are  at  risk  for  neurological
impairment,  developmental  delay,  and  later  epilepsy. 8-12
Despite  increasingly  sophisticated  neonatal  intensive  care,  neonatal  seizures
remains  a challenge.8-13 Neonatal seizures can be due to various causes like hypoxic-
ischemic encephalopathy, intracranial hemorrhage, meningitis, hypoglycemia,
hypocalcemia, congenital malformation, etc.1  The most important factor that predicts
their outcome is the underlying etiology.14 Patients with hypoxic encephalopathy
(HIE), intraventricular hemorrhage (IVH) and neuronal migration disorders (NMD) are
reported to have the worst prognosis. Etiologic  profile  of  neonatal  seizures  is  also
changing  over  the  years  due to   advanced  development   in  obstetric  and  neonatal
management  that  have  changed  the  spectrum  of  insults  to  which  the  immature
brain  is  exposed.15-18
The  mortality  of infants  developing  seizures  during the  neonatal  period
has  shown  a  decreasing  trend  over time.  In  earlier  studies,  the  mortality  was  as
2high  as  40%, but  decreased  in  subsequent  reports  to  20%. 8,9,19-22  As opposed  to
this  increase  in  survival,  the  prevalence of long-term  neurodevelopmental  sequelae
in  survivors has  remained  unchanged  at  30%.8,19,23 However,  neonatal  seizures
remain  an  important  predictor  of  future  neurological complications. 6,20  In  addition
it  may  be  associated with other  permanent  neurological disorders such  as  mental
retardation  and  cerebral  palsy. The occurrence of epilepsy after neonatal seizures
varies in frequency  as  shown  in  previous  studies  from  3.5  to  56%   according  to
sample  selection.12
The  aims   of   the   current   study   were   to   assess   the   neurodevelopmental
outcome  of neonatal seizures and  prognostic indicators of  outcome (like onset of
seizure, type of seizure, EEG changes, etc )  for  infants  surviving  neonatal  seizures.
                         REVIEW  OF  LITERATURE
3REVIEW OF LITERATURE
DEFINITION
“ Clinical   seizures”   may   be   defined   as   paroxysmal   alterations   of
neurologic  function,  including  behavioural,  motor,  and/or  autonomic  changes.
PATHOPHYSIOLOGY
Seizures  are  the  most  common  and  distinctive  clinical  manifestation  of
neurologic dysfunction  in  the  newborn  infant8. Neonatal  seizures  often  herald
potentially devastating  forms  of  brain  injury.   Decreased   seizure   threshold    in   the
newborn  period  reflects  the  undergoing  active  developmental process  in  the  immature
brain.  The   newborn   brain   has   transient   overdevelopment   of   excitatory   system
when   compared   to   inhibitory   system,   for   example   there   is   a   transient   over
expression   of   Glutamate   receptors   and   relative   paucity   of   glutamate   reuptake
transporters. These  two  factors  causes  prolonged  and  intense  contact  of  glutamate
with  the  post   synaptic  receptors.  Moreover  these  immature  glutamate  receptors
are  more  permeable  to  cationic  influx,  facilitating  membrane  depolarisation  and
seizure   activation.   In   contrast,   inhibitory   GABA   ion   channels   are   under
expressed  in   immature  brain. In  certain  areas  of  brain  these  GABA  ion  channels
tend   to   depolarize   rather   than    hyperpolarizing.  In   addition   to   these   cellular
effect,  there are other mechanism for seizures in newborn; eg: ‘differential
development  of   neural  system’   where  there  is  relatively    advanced  development
of  excitatory  projections  in  substantia  nigra,   compared  to  inhibitory  pathways;
so  it    act   as  an   amplifier    rather    than    inhibitor    of    epileptic    discharges,
predisposing  to  neonatal seizures.24
4INCIDENCE  OF  NEONATAL   SEIZURE
Incidence   of   neonatal   seizures   varies   widely   across   studies.   In   earlier
reports,  seizures occurred  in  up  to  3/1,000  full-term  infants  and  up  to  60/1,000
premature  infants. National  Collaborative  Perinatal  Project  reported  an  incidence
of  5  per  1000  live births  between  1959-1966.25   The national  Neonatal – Perinatal
Database  of  India  that  collated  information  from  18  centres  across  the  country
in  the  year  2002-2003  had  reported  an  incidence  of  1.26
SEIZURE MIMICS
Neonatal   seizures   differ   considerably   from   seizures   observed   in   older
children, principally  because  the  immature brain  is  less  capable  of  propagating
generalized  or  organized electrical discharges.  Continuous  video-EEG monitoring
has  demonstrated  a  number  of  important  facts  about  seizures  in  the newborn.
First,   nonepileptic   mimics   of   clinical   seizures   are   common   in   the   newborn.
These  seizure-like  behaviour  patterns  may  occur  in  the  normal  newborn  (e.g.,
non-nutritive  sucking)  and  nonepileptic  paroxysmal  clinical  changes  are  common
in encephalopathic  newborns. Differentiation  of  nonepileptic  movement  from
seizure   is   difficult   in   newborns.  Particularly  clonic   seizure   is   difficult   to
differentiate  from  jitteriness. Following   clinical  observation  helps  to  resolve  the
difference.27
? Jitteriness  is  not  accompanied  by  abnormal  eye  movements.
? Jitteriness  may  be  spontaneous  or  stimulus  sensitive.
? The  flexion  and  extension  phases  of  the  tremor  are  equal  in  amplitude
compared  to  the  unequal  phases  observed  with  clonic  seizure  movements.
5? Jitteriness   may   be   stopped   by   passive   flexion   or   repositioning   of   the
affected body  part.
Benign  neonatal  sleep  myoclonus  occurs  during  active  sleep  in  healthy
preterm  and  in  some  term  babies. Myoclonus  may  be  florid  and  consist  of  either
bilateral   synchronus   or   asynchronus   or   asymmetric   movements   that   are   not
stimulus  sensitive. These  myoclonus  ceases  on  arousal  from  sleep.  EEG  shows
no  epileptiform  activity  or  background  abnormalities.  Benign  neonatal  sleep
myoclonus  tend  to resolve  over  months28,29
CLASSIFICATION
Clinical seizure types may be categorized broadly into four groups:8,24
Subtle  seizure:  They   are   called   subtle,   because   the   clinical   manifestation   are
mild  and  tend  to  be  missed  frequently.  Subtle  seizures  include  a  broad  spectrum
of  behavioural phenomena,  occurring  in  isolation  or  in  combination. They  are  the
commonest  type  and  account  for  50%  of  cases.
Common  manifestation  of  subtle  seizures  are:-
Ocular: tonic  horizontal  deviation  of  eyes  or  sustained  eye  opening  with  ocular
fixation  or  cycled  fluttering.
Oral- facial- lingual  movements: chewing,  tongue  thrusting,  lip  smacking,  etc.
Limb  movements: cycling,  paddling,  boxing  jabs,  etc.
Autonomic  phenomenon: tachycardia or  bradycardia.
6Apnea:  this  is   a  rare  manifestation  of  seizure.   Apnea  due  to  seizure  activity
may  have    accelerated  heart  rate  or  normal  heart  rate  when  evaluated  for  20
seconds. Bradycardia  may  occur  later  secondary  to  hypoxia.
The   association   between   clinical   and   EEG   events   is   variable,   most   subtle
seizures   are  not   associated   with   EEG   seizures.  Based   on   their   inconsistent
association  with  EEG seizures,   as  well   as  their   poor  response  to  conventional
anticonvulsants,  many  consider these  subtle  seizures  to  be  nonepileptic  “brainstem
release  phenomena.”
 Clonic  seizure: They are  stereotypic  and  repetitive  biphasic  movements  with  a
fast  contraction   phase   and   a   slower   relaxation   phase.  The   rhythm   of   clonic
seizures   tends   to   be  slower   in   the   newborn   than   in   older   children.   Clonic
seizures  may  be  unifocal,  multifocal,  or generalized.  Clonic  seizures  that  remain
unifocal  are  usually  not  associated  with  loss  of consciousness.  The  most  common
cause  for  clonic  seizures  that  remain  unifocal  is  neonatal  stroke.  These  seizures
are  commonly  associated  with  EEG  changes.
Tonic  seizures: This  type  of  seizure  refers  to  sustained  flexion  or  extension  of
axial  or  appendicular  group  of  muscles. Tonic  seizures  may  be  generalized  or
focal  and  may  mimic  decorticate  or  decerebrate  posturing.  They  are  common  in
premature   infants   with   major   neurologic   dysfunction   or   severe   intraventricular
hemorrhage. The background  EEG  pattern  tend  to  have  multifocal  or  generalized
voltage   depression  and   undifferentiated   frequencies   and   in   some   cases,   a
markedly  abnormal  burst suppression  pattern. Overall,  the  prognosis  of  tonic
seizure  is  very  poor.
7Myoclonic  seizure:  This   type   of   seizure   manifest   as   single   or   multiple,
lightening   fast   jerks   of   upper   limb   or   lower   limb.  This   type   of   seizure   is
differentiated  from  clonic  seizure  by  rapid  jerks,   absence  of  slow  return  and
predilection  for  flexor  groups  of  muscle.  EEG  changes  include  burst  suppression
pattern,  focal  sharp  waves  and  hypsarrhythmia.  Myoclonic  seizures  are  usually
associated  with  a  poor  long-term outcome.
CAUSES  OF  NEONATAL  SEIZURE
Once  neonatal  seizure  is  suspected ,  focus  should  be  on  the  exclusion  of
rapidly  correctable  and  potentially  injurious  conditions,  including  hypoglycemia,
hypocalcemia,   hypomagnesemia,   among   others.   Thus,   when   neonatal   seizures
occur,   immediate  attention   must   be   directed   towards   the   identification   of   an
underlying  etiology  to  permit  rapid  and  appropriate  intervention   and  meaningful
prediction  of outcome.30  Following  are  the  causes  of  neonatal  seizures:
? Hypoxic  ischemic  encephalopathy
? Intracranial  hemorrhage
? Central  nervous  system  infections
? Metabolic  disturbances
? Cerebral  dysgenesis
? Unknown
? Epileptic syndromes
Hypoxic- ischemic Encephalopathy (HIE): The  leading  cause  of  neonatal  seizure
is   cerebral   hypoxic-ischemia,   which   may   occur   in   antenatal,   intrapartum   or
neonatal   period.   Perinatal   asphyxia   is   implicated   in   25%  to   40% of   neonatal
8seizure. Most  seizures (50%-65%)  due  to  HIE,  manifest  within  12  hours,
remaining  manifest  within  24- 48  hours  of  age. The  seizure  onset  in  each  case  is
likely  influenced  by  the severity,  duration,  and  onset  of  the  intrauterine  asphyxial
insult. It  is  likely  that  more severe  insults  are  followed  by  earlier  onset  seizures,
but   this   is   not   firmly   established.  Subtle   seizures   are   most   common  type   of
seizure  following  HIE.
Intracranial  hemorrhage: Approximately 10%   of  neonatal  seizure  is  caused  by
intracranial  hemorrhage. The  location  of  hemorrhage  and  clinical  features  varies
with  the  gestational  age.   Primary  subarachnoid  hemorrhage  is   most  commonly
seen  in  term  newborns.  It  commonly  occurs  after  prolonged  labour. Seizures  are
usually  focal  or  multifocal,  occurring  on  the  second  day  of  life.  Infants  appear
relatively   well   between   seizures.  Infants   with   seizures   associated   with   primary
subarachnoid   hemorrhage   have   a   good  long   term  outcome  in   90%  of   cases.
Posthemorrhagic  seizures  in  preterm  infants  have  different  features  and  a  more
ominous   prognosis.   Seizures   are   usually   associated   with   severe   IVH   or   its
complications, periventricular  hemorrhagic  infarction.  Seizures  due  to  severe  IVH
usually  occur  within  3  days  of  life  in  sick  preterm  babies. The  seizures  are
usually  generalised  tonic  seizures. Seizures  associated  with  periventricular
hemorrhagic  infarction  tend  to  occur  after  the  3rd  day  of  life.
Central  nervous  system  infection: Infecions  from  a  variety  of  agents,  including
viral,   bacterial,   or   others   like   toxoplasmosis,   may  have   neonatal   seizure   as   a
prominent  part  of  their  presentation. Intrauterine  infection  due  to  toxoplasmosis
or  cytomegalo  virus,  that  are  severe  enough  to  produce  neonatal  seizure  usually
manifest  within  3  days  of  life.  Viral  infections  like  herpes  simplex  virus(HSV)
9type-2 , acquired during  intrapartum  period   manifest  neonatal  seizure  within  first
day  of  life,  whereas  HSV-1  have  a  delayed  presentation. Bacterial  meningitis  due
to  Group  B  streptococcal  meningitis  may  also  have  biphasic  presentation.
Mechanism  of  seizure  in  meningitis  may  be  through  direct  cerebritis  or  vaso-
occlusive  injury  with  secondary  seizures.
Metabolic  disturbances: Two   types   of   metabolic   disturbances   may   result   in
neonatal  seizures.
1)  Transient  metabolic  disturbances: These include  hypoglycemia,  hypocalcemia,
hypomagnesemia,  and  hyponatremia.
2)  Inborn  error  of  metabolism: These  are  uncommon  cause  of  neonatal  seizure.
Certain   conditions   more   likely   to   be   associated   with   neonatal   seizure   include
non-ketotic  hyperglycinemia,  pyridoxine  dependency,  sulphate  oxidase  deficiency,
glutaric  aciduria  type-II, urea  cycle  defect. Most  common  diagnostic  abnormalities
associated   with   these   conditions   include   metabolic   acidosis,   hyperammonemia,
hypoglycemia,  and  ketosis.  Recognition  of  these  conditions  are  important  because
some   metabolic   forms   are   transient   that   resolve   over   time   e.g.  Non-ketotic
hyperglycinemia.  Secondly   some   of   the   conditions   are   treatable  e.g.  Pyridoxine
dependent  seizure.  In  both  the  conditions  early  diagnosis  and  management  may
prevent  or  limit  brain  damage.
Cerebral  dysgenesis:  number  of  dysgenetic  cerebral  lesions  may  be  associated
with  neonatal  seizures.  Conditions  most  commonly  associated  are  neuronal
migration  disorders (lissencephaly,  heterotopias)  or  disorders  of  neuronal
organization (polymicrogyria).
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Unknown  etiology : approximately  10%  of  neonatal  seizures  are  due  to  unknown
etiology.24
Epileptic  syndromes  in  the  newborn  infant: There  are  two  benign  and  three
malignant  epileptic  syndromes  presenting  with  seizures  in  the  newborn infant.
Benign condition  are  i) benign  familial  neonatal  seizure
                                    ii) benign  idiopathic  seizure.
Three malignant  conditions  are
 i) neonatal  myoclonic  encephalopathy
ii) Ohtahara  syndrome
iii) Migrating  partial  seizures  of  infancy  (Coppola  syndrome).
All  three  conditions  carry  worst  prognosis.
DIAGNOSIS
The  evaluation  should  start  with  a  careful  history  of  pregnancy,  labour
and delivery,  and  family,  followed  by  a  detailed  clinical  examination  for  signs  of
dysmorphism,  trauma,  skin lesions,  and  unusual  odours.  The  neurologic
examination  should   include   a   careful   and   accurate   clinical   description   of   the
seizure  features,  the infant's  mental  status,  and  cranial  nerve  examination  as  well
as  interictal   movements,  muscle  tone,   and  deep  tendon  and  primitive  reflexes.
Certain  clinical  signs  may suggest  specific  etiologies  and  may  facilitate  a  more
rapid  etiologic  diagnosis.
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Laboratory  investigation
Investigation  that  is  done  in  all  newborns  with  neonatal  seizure  are  blood
glucose,   hematocrit,   serum  electrolytes,   serum  bilirubin  if   newborn is  clinically
jaundiced.  CSF  analysis  should  be  done  in  all cases  as  seizures  may  be  the  first
sign  of  meningitis  and  also  it  may  be   coexisting, when  other  causes are
identified. CSF  analysis  may  be  withheld  when  there  is  cardiopulmonary
instability   or   severe   birth   asphyxia.  Cranial   ultrasound   and   EEG   are  routinely
done  for  all cases  of  neonatal  seizure. Ideally  an  EEG  study  should  be  recorded
as  soon  as  a  seizure  is   suspected  and  preferably  not  later  than  24  hours  after.
If  such  an  EEG  is normal,  particularly  if  a  suspected  clinical  event  is  captured
during   the   EEG   recording,   then   subsequent   EEGs   are   only   indicated   if   the
clinical  spells  keep recurring. EEG   should   be   performed   for   at  least   1  hour.31
Interictal  EEG  is  useful  for  long  term  prognosis  of   neonates  with  seizure. An
ABG   should    be    performed   when   Inborn   error   of    metabolism  is   strongly
suspected. Specific  investigation  are  needed  when  neonatal  seizures  are  not
responding  to  usual  line  of  management.  These  include  neuroimaging  CT/MRI ,
screening  for  congenital  infections  (TORCH),  inborn  error  of  metabolism.  Ultra
sonogram   of   the   cranium   is   an   excellent   tool   to   diagnose   intraventricular
hemorrhage  and  parenchymal  hemorrhage.
TREATMENT
 Initial   management   includes   stabilization   of   airway,   breathing   and
circulation  and  temperature.  Oxygen  should  be  delivered  through  mask,  IV
access  and  blood  should  be  collected  for  blood  glucose  and  other  investigations.
A  brief  history  and  rapid  clinical  examination  should  be  done.
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i) Hypoglycemia  is   corrected  with  2  ml/kg of  10%  dextrose  bolus  through  IV
followed  by  6-8 mg/kg/min  infusion.
ii)  Hypocalcemia   is   corrected   after   ruling   out   hypoglycemia   with   bolus   of   2
ml/kg  of  10%  calcium  gluconate  over  ten  to  fifteen  minutes  under  strict  cardiac
monitoring   followed   by   8   ml/kg/day   for   3   days   if   investigation   shows
hypocalcemia.  If   still   seizure   persist   after   correction   of   hypocalcemia   50%
magnesium   sulphate   at   dose   of   0.25   ml/kg   is   given   as   i.m  injection.   When
seizure   persists   even   after   correction   of   hypoglycemia   and   hypocalcemia
antiepileptics  are  considered.
iii) Phenobarbitone : It  is  the  drug  of  choice  in  neonatal  seizure. A  loading  dose
of  20  mg/kg  bolus  is  given  under  cardio respiratory  monitoring  over  20  minutes,
rate   of   administration   should   not   be   more   than   1mg/kg/min.  If   seizure   still
persists,  a  repeat  dose  of  10mg/kg  is  given  every  30  minutes  till  40mg/kg  dose
is  reached. Maintenance  dose  of  3-5 mg/kg/day  in  2  divided  doses  is  started  12
hours  after  the  loading  dose.
iv) Phenytoin is  considered  when  seizures  are  not  controlled  with  phenobarbitone.
It  is given  as a loading  dose  of  20  mg/kg  over 20  minutes  under  cardiac
monitoring.  Repeat  dose  10 mg/kg  is  given  if  seizure  is  not  controlled.  This  is
followed  by   maintenance   dose   of   3-5   mg/kg/day   in   2  -  4   divided   dose.  It   is
preferably  discontinued  before  the  infant  is  discharged.  Fosphenytoin,  a  prodrug
of   phenytoin  causes   less   degree   of   hypotension   and   cardiac   arrhythmia   when
compared  with   phenytoin.  1.5  mg   of   fosphenytoin   is   equivalent   to   1   mg   of
phenytoin.
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v) Benzodiazepams  are  required in  up to  15%  of  neonatal  seizure. Commonly  used
are  Diazepam,  Lorazepam,  and  Midazolam. Diazepam (0.25 mg/kg  I.V, 0.5 mg/kg
rectally)  is   generally   avoided   as   it   has   short   duration   of   action,   narrow
therapeutic  window  and  because  of  presence  of  sodium  benzoate  as  preservative.
Lorazepam (0.05 mg/kg  I.V  over  2-5 minutes)  has  longer  duration  of  action  and
less  adverse  effects  when  compared  to  diazepam. Midazolam (0.15 mg/kg  as I.V
bolus) is  faster  in  action  than  lorazepam  and  it  can  be  used  as  infusion(0.02-0.06
mg/kg/hr).
According  to  Volpe,  response  to  anticonvulsants  are  40%  after  initial  20
mg/kg  of   phenobarbitone, 70%  after  40 mg/kg  of  phenobarbitone, 85%  after  20
mg/kg  of  phenytoin,  95%  to  100%  after  0.05mg/kg of  lorazepam.  Second  line
drugs  are  used  when  seizures  are  refractory  to  above  line  of  management. They
are  lidocaine,  paraldehyde,  sodium  valproate.  Lidocaine  is  usually  started  with  4
mg/kg/hr  I.V   on   first   day   and   reduced    by   1   mg/kg/hr   on   subsequent   day.
Paraldehyde  0.1 ml to 0.2 ml/kg  i.m   or  0.3 ml/kg  mixed  with  coconut  oil  in  3:1
ratio and  given  per  rectally. Sodium  valproate  20-25  mg/kg  loading  dose  followed
by  5- 10  mg/kg  12th hourly is  used.
Other  therapies: Pyridoxine- 50  to  100  mg  I.V  followed  by  10  to  100  mg/day
depending  upon  response  have  been  used.
Exchange  transfusion-  indicated  in  life  threatening  metabolic  disorders, accidental
injection  of  local  anaesthetic ,  transplacental  transfer  of  maternal  drug  (e.g
chlorpropamide)  and  in hyperbilirubinemia to prevent bilirubin  encephalopathy.
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PROGNOSIS
The  most  important  determinant   of  outcome  is  underlying  neurological
illness.  Additionally,  seizures  of  early  onset,  frequent  or  prolonged  seizures,  and
seizures  that  are  refractory  to  multiple  anticonvulsant  treatment  are  often
associated with  poor  prognosis. In  infants  with  neonatal  seizure  after  arterial  or
venous  vaso- occlusive  disease,  seizure  is  relatively  benign.  Approximately  75%
of  infants  with  cerebral  vein  thrombosis  have  favourable  outcome.  Infants  with
neonatal   seizure  secondary  to  HIE  have  50%  chance  of  normal  development.
Similarly,  about  50%  of  infants  with  neonatal  seizure  due  to  bacterial  meningitis
have  favourable  outcome.(8)   In  term  newborns,  normal  background  activity  on
the   EEG   is  rarely   associated   with   neurological   sequelae,   whereas   severe
abnormality  of  background  activity,  e.g.,  burst  suppression  or  marked  voltage
suppression   is   associated   with   abnormal   outcome  in   over   90%  of   cases.  The
number  of  electrographic seizures  and  the  rate  of  improvement  of  serial  EEG's  is
also  a  useful  prognostic  factor.32 Neonatal  seizures  in  preterm  infants  shows  high
mortality  up  to  80%  in  some  studies,  and  a significantly  higher  risk  of  adverse
neurologic  outcome  in  survivors,  when  compared  to  term  infants.
The  outcome  of  neonates  with  neonatal   seizures  has  changed  in  recent
years  due  to  improved  prenatal  care,  better  obstetrical  care  and  intensive
neonatal  care.  However,  neonatal  seizures  remain  an  important  predictor  of
future  neurological  complications. Various  studies  have  been  conducted  to
identify  risk  factors  for  poor  neurological  outcome.
TEKGUL et  al   conducted  a  study  in  Boston  between  1997  and  2000,  included
all  newborns   admitted   to   the   NICU   to   describe   etiologic   profile   of   neonatal
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seizure,  the  neurodevelopemental  outcome,  and  reliable  prognostic  indicators  of
outcome  for  infants  surviving  neonatal  seizures.  Eighty-nine  term  infants  with
clinical  neonatal  seizures underwent  neurologic  examination,
electroencephalography (EEG),  neuroimaging,  and extensive  diagnostic  tests  in  the
newborn  period. After  discharge,  all  infants  underwent regular  neurologic
evaluations    at   12   to   18   months   and   formal   neurodevelopmental  testing.
Prognostic   value   of   seizure   aetiology,   neurological   examination,   EEG   and
neuroimaging  were  assessed  in  this  study. Mortality   observed  in  this  study  was
7%. Seven  causes  for  the seizures  were identified  in  78  babies ,  most  common
etiologies  for  neonatal  seizures  were global  cerebral hypoxic-ischemia, cerebral
vaso-occlusive  lesions,  and  intracranial  hemorrhage. Global  cerebral  hypoxia-
ischemia(HI),  the  most  common  etiology,  was  responsible  for  the  large  majority
of   infants   with   poor   long-term   outcome. The statistical  relationship  between
neonatal   seizure   etiology   and   poor   outcome   was   highly   significant. Etiologies
associated  with  poor  outcome  included  cerebral  dysgenesis,  global  cerebral  HI,
and  central  nervous  system  infection. Conversely,  infants  with  focal cerebral  HI,
transient  metabolic  disturbances,  or  idiopathic  seizures  had  an  almost universally
favorable  outcome. Type  of  seizure  was  not  found  to  be  associated  with  poor
neurodevelopmental  outcome. Normal  neurological  examination  during  NICU  stay,
within  28  days  of  life  and  in  early  infancy  had  favourable  outcome  at  1  year
and  18  months. However  abnormal  neurological  examination  during  the  neonatal
period   and   in   early   infancy   was   not   a   reliable   predictor.  Moderate   to  severe
background  EEG  abnormalities  were  strong  predictors  of  poor  neurological
outcome.  These   background   EEG   pattern   has   added   significant   value   to   the
prognostic  power  over  aetiology,  only  in  the  global  hypoxic-ischemic  group
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regardless  of  the  timing  of  the  EEG  . There  was  no  use  of  considering  the  rate
of  recovery  of  EEG  in  predicting  the  poor  neurodevelopmental  outcome. Normal
neuroimaging   and   infants   with   focal   cortical   infarcts   had   favourable
neurodevelopmental  outcome,  whereas  infants  with  deep  grey  matter  lesions  or
multifocal  or  diffuse  cortical  lesions  invariably  had  poor  neurodevelopmental
outcome. Normal  neuroimaging  and  mild  abnormal  EEG  or  normal  EEG  in  the
neonatal  period  had  favourable  neurodevelopmental  outcome. The  study  concludes
that  seizure  aetiology  and background  EEG  pattern  remains  the  powerful
prognostic  factors.14
PISANI et  al   conducted  a  study  in  106  newborns  who  had  neonatal  seizures.
They  were  followed  up  for  24  months  and  neurological  outcome  was  measured.
Six  variables  were  identified  as  the  most  important  independent  risk  factors  for
adverse  outcome  and   were   used   to   construct   a   scoring   system:   birth   weight,
Apgar   score   at   1  minute,   neurologic   examination   at   seizure   onset,   cerebral
ultrasound,   efficacy   of  anticonvulsant   therapy,   and   presence   of   neonatal   status
epilepticus.  Birth  weight  less than  2.5  Kg  in  babies  with  neonatal   seizure  had
significant  adverse  neurological  outcome. Neuroimaging  in  neonatal  seizure  with
cranial  ultrasound  findings  of  IVH  of  grade  III  and  IV,  intraparenchymal
hemorrhage,  periventricular  leukomalacia,  cerebral  malformation  were  strong
prognostic   indicators   of   adverse   neurological   outcome.  Neonatal   seizures   with
status  epilepticus  was  associated  with  poor  neurological  outcome. Prolonged
seizures  can  be  related  to  specific  clinical  conditions  with  a  known  favourable
outcome,  like  focal  clonic  seizure  in  neonatal  hypocalcemia;  whereas  neonatal
status  epilepticus  is  almost  always  of  symptomatic  origin  and  is  more  likely to
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be  related  to  diffuse  and  extensive  structural   brain  injury,   which  is   likely  to
have  a  significant  influence  on  outcome. Moderately  abnormal  neurological
examination,  no  response  to  anticonvulsant  therapy  and  Apgar  score  less  than  7
at   one   minute   of   life   were   independent   risk   factors   for   adverse   neurological
outcome. EEG  with  moderate  to  severe  abnormality  had  poor  neurodevelopmental
outcome.  Based  on  above  six  variables  two  scoring  system  were  proposed  one
with  six  variables  excluding  EEG  abnormality,  second  scoring  system  including
the  EEG  abnormality. The  clinical  score  was  designed  to  be  easily  applicable  in
the  first  day    of  the  neonatal seizures  and  accurate  in  identifying   newborns  who
will  have  an  unfavourable  outcome. Type  of  seizure  and  onset  of  seizure  did  not
had  significant  adverse  neurological  outcome.33
IYPE et  al   conducted  a prospective  follow-up study  of  newborns  with  seizures,
to  determine  the  predictors  of  adverse  neurological  outcome. 135  babies  were
recruited;  of whom  10  died  and  25  were  lost  to  follow  up. All enrolled newborns
were followed up at 2 and 4 months of age. The  outcome  was  defined  as  “abnormal”
in  any  of  three conditions: (i)  death  either  while  in  the  NICU  or  during  follow
up (ii)  post  neonatal epilepsy (seizure recurrence) or (iii)  abnormal
neurodevelopment  defined  as  the  presence of  a  motor  deficit,  developmental
delay  or  spasticity.  A  few  neonates  were  followed up  to  8  months  of  age. Out
of  100  who  came  for  follow  up,  32  had  developmental  delay.  Of  those  with
developmental  delay  7  of  the  babies  followed  up  had  post neonatal  epilepsy, 24
had  spasticity, 10  had  abnormal  vision  and  5  had  defective hearing  at  the  four
month  follow-up. 68  babies  were  normal  at  follow  up. Birth  weight,  gestational
age,   head   circumference   at   birth,   and   age   of   first   seizure   could   not  predict
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adverse  outcome  in  this  cohort.   EEG  changes  were  associated  with  abnormal
development  although  it  could  not  predict  post  neonatal  epilepsy. The  study  also
found   a  significant   association   between   patients   with   an   adverse   neurological
outcome  and  the  interictal  EEG. Predominance  of  spike  waves  in  the  EEG  can
be  probably  taken  as  a  marker of  abnormal  neurological  outcome. Hypocalcemia
was  significantly  associated  with mortality. No  risk  factors  could  be  identified  for
post  neonatal   epilepsy. The  study  concluded  that   majority  of  neonatal   seizures
had   normal  outcome  with   no  developmental   delay   or   neurological   deficit.
Predominantly  spike  waves  in  the  EEG  was  predictive  of abnormal  neurological
outcome.34
RONEN et  al   conducted  a  population  based  prospective  study  in  Canada to
examine  the   outcome  and   to   explore   for   prognostic   markers   in   a   cohort  <10
years  following neonatal   seizures.  90  subjects  were  involved  in  the  study.
Variables   associated   with  poor   prognosis   were   Sarnat   stage   III   or   equivalent
severe  encephalopathy,  cerebral dysgenesis,  complicated  intraventricular
hemorrhage,  infections  in  the  preterm  infants, abnormal  neonatal  EEGs,  and  the
need  for  multiple  drugs  to  treat  the  neonatal seizures. Pure  clonic  seizures
without  facial  involvement  in  term  infants  suggested favorable  outcome,  whereas
generalized  myoclonic  seizures  in  preterm  infants  were associated  with  mortality.
The  severity  and   timing  of  the  pathologic  process   continues  to  be  the  major
determinants  for  outcome.35
BRUNQUELL et   al   studied   77   newborns   admitted   in   NICU   to   determine
whether  clinical  features  of  neonatal  seizures  were  of  value  in   predicting  the
neurological  outcome. 43%  had  cerebral  palsy  at  mean  follow  up  of  3.5  years.
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Subtle  seizure  and  generalized  tonic  seizures  had  higher  prevalence  of  cerebral
palsy,  mental  retardation and  epilepsy. In  addition  subtle  seizures  were  associated
with   abnormal  neurological  examination  on  follow  up. Other  seizure  types  did
not  show  significant  association  with  adverse  neurological  outcome. The  study
also  found  that  more  than  two  seizure  types  had  significant  adverse  neurological
outcome. The  study  concludes  that clinical semiology  is  predictive  of  outcome  in
neonates   with   seizures   and   suggests   the  presence   of   unique   pathophysiologic
processes  for  different  seizure  types.36
GARFINKLE et  al  conducted  a  retrospective  analysis  of  62  term  neonates  with
clinical  neonatal  seizure  to  determine potential   clinical   prognostic   factors   for
term infants  with  neonatal  seizures  subsequent  to  intrapartum  asphyxia. A  total
of  23  (37%)  infants  had  a  normal  outcome,  34  (55%)  survived  with  1  or  more
neurodevelopmental  impairments  (23  cerebral  palsy,  28  global  developmental
delay,  15 epilepsy,  with  18  having  combination  of  two,  and  9 having  all  three),
and  5  (8%)  died.  Six  variables were  associated  with  an  adverse  outcome,  but
only  the  presence  of  meconium aspiration,  a  low (? 3)  1-minute  Apgar  score,
seizure   type   other   than   focal   clonic,   and  moderately   severely   abnormal
electroencephalography  (EEG)  background  findings  were independently  associated
with  an  adverse  outcome.37
NUNES et  al   conducted   a   cohort   study   in   a   tertiary   care   hospital.  3659
newborns   were   admitted   and   2.7%   were   diagnosed   to  have   seizures.  25   died
during  the  neonatal  period  and  another  9  died  during  first  year  of  life. 35  had
developmental   delay,   19   had   post   neonatal   epilepsy   and   11   had   association
among   this   two   comorbidities.  Most   common   etiology   was   hypoxic   ischemic
20
encephalopathy (51%)  followed  by  transient  metabolic  disturbances (14%),
infection (9%)-  congenital, septicemia, bacterial meningitis intraventricular
hemorrhage (6%),  venous  infarct (3%),  inborn  error  of   metabolism  and cerebral
dysgenesis  (2% each). It  was  not  possible  to  determine  etiology  of  seizures  in 10
patients. No  significant  statistical  relationship  between  etiology  and  the  outcome
studied   was   observed.  Prematurity,   low   birth   weight,   abnormal   neonatal
neuroimaging,   abnormal  postnatal   EEG,   postnatal   neuroimaging   and   earlier
postnatal  seizures  were  risk factors  for  developmental  delay. The  study  concluded
that  neonatal  seizures    predominated   in  term  newborns  and  on  follow  up  had
increased  risk  of  developmental  delay  and  post  neonatal  epilepsy. Abnormal  post-
neonatal   EEG   and  neuroimaging   were   good   predictors   for   the   outcome   of
developmental  delay.38
TUDEHOPE et  al  studied  156  newborns  with  neonatal  seizures  over  5  years  to
describe  clinical   spectrum   in   neonatal   seizure   and   its   outcome.  Incidence   of
neonatal  seizure  was  3/1000  live  births. Predominant  risk  factors  for  seizure  were
prematurity,   intrauterine   growth   retardation,  low   5   minute   apgar   score,
preeclampsia,   antepartum  hemorrhage,   twin   pregnancy   and   breech   presentation.
The  predominant  seizure  type  was  tonic  in  28.6%,  multifocal  clonic  in  27.2%,
subtle  in  18.4%,  myoclonic  in  15.0% and  focal  clonic  in  8.8%.  Mortality  (31%)
and  long-term  disability  (43%)  rates  were high. Tonic  seizures  had  the  highest
mortality  and  morbidity.  Causative  factors  were determined  in  95%  of  convulsing
infants,  most  frequent  being  hypoxic-ischaemic encephalopathy  (40.3%)  and
cerebroventricular  haemorrhage (30.5%). A  poor  long-term prognosis  was
associated  with  prolonged  convulsions,  tonic  and  multifocal  clonic convulsions,
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convulsions  due  to  asphyxia  and  cerebroventricular  haemorrhage  and  an abnormal
neurological  examination  at  discharge.39
ARTHUR et  al   report  on  their  experience  gained  through  a  prospective  study
of  144  infants  who  developed  seizures  during  the  first  3  weeks  of  life.  Only
full-term  neonates  weighing  2.5 kg  or  more  were  included. Follow up  averaged
four  years. Seven  subjects  were  lost  on  follow  up  leaving  a total  of  137. The
study  showed  high  mortality  and  morbidity  for  neonates  with  seizure  states,  the
outcome  being  poor  for  half  of  the  cases. The  study  found  out  that  prognosis
based  on  abnormal  or  normal  neurological  signs  in  a  convulsing  neonate  showed
poor   correlation   with   the   state   of   the   child   when   re-evaluated    years   later.
Neonates   with   seizure   and   normal   EEG   had     86%   chance   of   normal
neurodevelopmental   outcome,   regardless   of   other   clinical   data’s.  In   contrast
neonates  with  either  a  flat,  periodic,  or  multifocal  EEG  had  only  7%  chance  of
normal  development.40
KIM et  al  studied   41   newborn   with   neonatal   seizure   over   three   years   and
evaluated   with   special   references   to   risk   factors,   neurological   examination,
laboratory  data,   neuroimaging,  EEG  abnormalities,   type of  seizure,   response  to
treatment  and  prognosis.  EEG  done  for  32  cases,  17  out  of  32  cases  showed
abnormal  EEG  record. Multifocal  seizure  was  predominant  seizure  type  followed
by  subtle  seizure., 30%  of  subtle  seizure  had  adverse  neurological  outcome, 24%
of  multifocal  seizure  had  adverse  neurological  outcome, while  myoclonic  seizure
had  favourable  outcome. Overall  prognosis  was  relatively  good  except  for  those
with  abnormal  EEG  background . The  study  concluded  that  neonatal  seizure  may
permanently  disrupt  the  brain  development,  hence  better  understanding  of  the
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neonatal  seizure’s  clinical  profile  and  their  management  may  lead  to  reduction
of  neurological  disability  in  their  later  childhood.6
ALMUBARAK et  al   conducted  a  retrospective  study   of  118  term  newborns
who  had  EEG  taken  in  the  first  month  of  life. They  were  followed  at  4  years
and  16  years  of  age  and  assessed  for  neurological  outcome. Clinical  neurologic
outcome   was   classified  into   favourable   when   patients   had   no   or   only   mild
limitation   in   assessment,  unfavourable   when   patients   had   moderate   to   severe
abnormalities  in  assessment. Of  the 118  neonates,  36 (30.5%)  had  favourable  and
82  (69.5%)  had  unfavourable  outcome. Sixty-seven  (57%)  had  abnormal  EEG
background  of  which  56  had  both  unfavourable outcome  and  epilepsy; 102 (86%)
had  sharp  transient  discharges  of  which  75  had unfavourable  outcome;  20  (17%)
had   ictal   epileptiform   discharges   of   which   18   had  unfavourable   outcome;   98
(83%)  had  abnormal  overall  EEG  record,  of  which  77 had  unfavourable
outcome.41
MELLITS et al    conducted   a   prospective   study   of   54,000   pregnant   women
enrolled  in  National  collaborative  perinatal  project (NCPP), infants  of  these
women   who   had   neonatal   seizure  were   followed   up   for   7   years   to   analyze
association   of   perinatal   events   with   adverse   outcome   and   to   analyze   factors
predictive  of  outcome.  5  minute  apgar  score  less  than  7,  need  of  resuscitation
after  5  minutes  of  life,  time  of  onset  of  seizure  and  seizure  lasting  for  more
than  30  minutes  were  best  early  predictors  of  significant  neurological  sequelae.42
SINGH M et  al   studied  107  babies  with  neonatal  hypoglycemia  over  15
months   period   to   analyze   the   neurodevelopmental   outcome   among   the
asymptomatic  hypoglycemia  and  symptomatic  hypoglycemia. Asymptomatic
23
hypoglycemia  was  found  in  64  newborns  and   43  were  symptomatic
hypoglycemia.  Asymptomatic  hypoglycemia  occurred  earlier  than  symptomatic
hypoglycemia. Symptomatic  hypoglycemia  had  lower  blood  glucose  than
asymptomatic  hypoglycemia.  On neurodevelopment  follow  up  the  mental
developmental  index  (MDI)  and  the psychomotor  developmental  index  (PDI)  of
symptomatic  babies  with  seizures  were significantly  lower  as  compared  to  those
with   other   features   of   hypoglycaemia   as   well  as   asymptomatic   babies.   The
duration  of   hypoglycaemia  was  directly  related  to  the MDI. This  study  indicates
that  there  is  a  need  to  identify  babies  vulnerable  to symptomatic  hypoglycaemia
more  precisely.43
A .L. GORDEN et  al  conducted  a  retrospective  study  in  Kenya  to  assess  the
neurological  and  developmental  outcome  of  neonatal  sepsis  and  neonatal  jaundice
in  rural  Kenya. The  study  recruited  87 cases,  23 were  neonatal   jaundice,  24  were
neonatal   sepsis,   and   40   were   controls.  Subjects   were   assessed   at   18   to   32
months  of  age.  The case  with  neonatal  sepsis  had  significantly  more  motor  and
eye-hand  difficulties    than  the  controls.44
Nair MKC et  al   developed  Trivandrum  Development  Screening  Chart (TDSC),  a
simple   screening   tool   to   assess  developmental   delay   at   the   community   level.
TDSC   was   designed   by   selecting   17   items   from   Bayley   Scales   of   Infant
Development  ( Baroda  norms). It  was  validated  both  at  hospital  and  community
level  against  standard  Denver  Development  Screening  Test. TDSC  has  sensitivity
of  66.7%  and  specificity  of  78.8%  which  makes it  an  acceptable  simple
screening  tool   even  for  community  level  workers.45
OBJECTIVES
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STUDY OBJECTIVES
To   assess   the   neurodevelopemental   sequelae   of   neonatal   seizure    of
newborns  admitted  in  NICU  at  Govt. Stanley  medical college  hospital.
To   identify   the   risk   factors   for   poor   neurodevelopemental   outcome   in
neonatal  seizures.
                               SUBJECTS  &  METHODS
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SUBJECTS AND METHOD
STUDY PLACE
This  study  was  conducted  at  neonatal  intensive  care  unit  of  Institute  Of
Social  Paediatrics  and  Govt.RSRM  hospital,  a  tertiary  care  hospital, Royapuram,
Chennai.
STUDY PERIOD: march  2010  to  august  2011
STUDY DESIGN: prospective  study
STUDY POPULATION: Newborns   admitted   in   neonatal   intensive   care  unit   of
Institute  Of  Social  Paediatrics  and  Govt. RSRM  hospital  during first  six  months
of  the  study  period  were  included  in  the  study.
INCLUSION CRITERIA: Following  newborns  were  included  in  the  study.
-Term  babies   weighing  >  2.5  Kg.
- Seizures  occurring   <  28  days  of  life.
EXCLUSION  CRITERIA:  Following  newborns  were  excluded  from  the study.
- Preterm  babies  < 37  weeks
- Babies  with  congenital  malformation  of  brain.
-birth weight <2.5kg
SAMPLE  SIZE :  All   newborns   who  satisfied   the   above   mentioned   inclusion
criteria  were recruited  during the  first  six  months  of  the  study.
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STUDY  METHODOLOGY
All   term  newborns   with   neonatal   seizures   admitted   in   NICU  satisfying
the inclusion  criteria  during  March  2010  to  august  2011  were  enrolled  in  the
study.  Informed  consent   was   obtained   from  the   parents   and   ethical  committee
approval  was  obtained  for  the  study. A  detailed  antenatal history  from  the  mother
was  obtained. Birth  history  regarding  mode  of delivery,  place  of  delivery,  Apgar
score,  birth  weight  were  obtained.  A detailed  clinical  examination  of  the  baby
was   done;   anthropometry  measuring   head   circumference,   length,   weight,   chest
circumference  was recorded .  Relevant   laboratorial  investigations  measuring
plasma  glucose,  serum calcium,  complete blood count,  serum C-Reactive protein,
blood  culture  and  sensitivity ,  lumbar  puncture  to  analyze  CSF, serum
electrolytes,   USG  cranium,     EEG   and   CT   brain   were  done  .  Results   were
documented  in  the   proforma .  Babies  were  treated  as per  the  standard  protocol.
Each  baby  was  followed  in  NICU  daily  till their  discharge  and  given  a  child
guidance  clinic  number (CGC).  After  discharge babies  were  followed  up  in  well
baby  clinic  and  department  of  paediatric neurology  at  1 , 3, 6, 9  and  12  months.
At  each  visit   babies  were  screened for  developmental   delay  using  Trivandrum
Developmental  Screening  Chart,  detailed  clinical  examination  assessing  tone,
reflex,  posture  and   paucity  of  movements. Trivandrum  development  screening
chart  consist  of  17  items  to  assess  developmental  progression  up  to  2  years  of
age. Each  item  is  represented  as  a  horizontal  bar,  left  end  of  the  bar represents
3%  and  right  end  represents  97%  of  the  population  who  should  have  achieved
the  milestone. Each  milestone  is  represented  by  a  bar.  Infant   is   considered  to
have  development  delay  if   it   has not  achieved  the  particular  milestone  at   the
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upper  limit  of  the  bar physiotherapy.  Anthropometry measurement  of  head
circumference (microcephaly  and macrocephaly),   weight  gain,  length  were
assessed  with  WHO  growth  charts. .    Babies  with  abnormal  neurodevelopemental
delay  were   treated   with   multidisciplinary   care;   and   at   the   end   of   one   year
various  data  were collected  and  statistical  analysis  was  done  with  SPSS  software.
STASTISTICAL  ANALYSIS
Statistical   analysis   of   neuro  developemental   outcome   was   done   using
Pearson –Chi  Square  test  with  SPSS  software.
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RESULTS  AND  ANALYSIS
In  our  study  conducted  at  Institute  Of  Social  Paediatrics,  newborns  with
neonatal  seizure  enrolled  from  March  2010  to  August  2011   were  followed till
one  year  of  age. Total  number  of  cases  were  108  babies  with  neonatal   seizure ,
of   which   8   parents   were   not   willing   to   get   enrolled   in   the   study.  Of   the
remaining  100  cases  enrolled,  4  babies  died  during  the  hospital stay  (4%),  96
babies  were  given  CGC  number  and  followed,  5  babies were  lost  in  follow  up.
At  the  end  of  one  year  91  infants  completed  the study.  At  the  end  of  the  study,
the   data   was   evaluated   using   Microsoft  Excel   Spreadsheet   and   the
neurodevelopment  outcomes  were  measured using  Pearson  Chi-square  test.
TABLE I
Sex of the baby
No of cases
N=100 %
Male 52 52
Female 48 48
Out  of  100  babies  enrolled  in  our  study,  52  were  male  babies  (52%)  and
48  were  female  babies  (48%). Among  the  100  newborns  4  newborns  died  (4%)-
3 male  babies  and  one  female  baby. Of  the  remaining  96  newborns ,  5  were lost
in  follow  up (5%)-  3  male  babies  and  2  female  babies.
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PLACE OF DELIVERY
                                                 FIGURE  I
1) Govt  RSRM  hospital  2) Corporation  hospital  3) PHC  4) HSC  5) private hospital
In  our  study  72  babies  were  delivered  at  Govt.  RSRM  hospital (72%),  18 babies
were  delivered  in  corporation  hospital  and  referred  to  our  hospital  for  neonatal
seizure  (18%), 4  newborns  were  delivered  and  referred  from  PHC  and  private
hospitals  each,  for  neonatal  seizure  (4%) , and  2 (2%) newborns  were  delivered  in
HSC  and  referred  to  our  institution  for  neonatal  seizure.
TABLE II
Sex of the baby
No of cases
N=91 %
Male 46 50.5
Female 45 49.5
At  the  end  of study  46  male  babies  and  45  female  were  left  for  assessment  of
neurodevelopemental  sequelae.
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MODE  OF  DELIVERY
FIGURE II
In  our  study  53  newborns  were  delivered  by  normal  vaginal  delivery  (53%) , 41
newborns  were delivered  by LSCS (41%),  4 newborns  were  delivered  by  forceps
delivery(4%). 2 newborns  were  delivered  by  vacuum  extraction(2%). Among  the  2
babies  born  by  vaccum  extraction  both  the  babies  expired  during  the  hospital
stay.  Among   4   cases   born   by   forceps   delivery   one   was   lost   in   follow   up,
another  one  expired  during  the  hospital  stay.
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                           ANTENATAL COMPLICATIONS
                                                 FIGURE III
In  our  study  14  mothers  (14%)  had  pregnancy induced hypertension, 8 mothers
(8%) had  diabetes  mellitus  of   which  1  mother  had   insulin  dependent  diabetes
mellitus  and   rest  of  them  gestational  diabetes  mellitus.5 mothers   had  maternal
fever(5%), 8 mothers  had  premature  rupture  of membranes (8%)  and  65  mothers
didn’t  had  any antenatal complications.
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ETIOLOGICAL PROFILE OF NEONATAL SEIZURE
FIGURE IV
Among  the  100  cases  33  (33%)  had  birth  asphyxia  , 27  newborns  (27%)
had   septicaemia,   20  newborns   had   hypoglycaemia(20%),   8   newborns   had
hypocalcemia,  2 newborns  had  intraventricular  haemorrhage  (both were  grade II
haemorrhage), diagnosed  with ultrasound  cranium.  one  newborn was    diagnosed  to
have   neonatal  stroke  who  presented  with  paucity  of  movements  of  left   upper
limb  and  the  left  lower  limb;  CT brain  showed  hypo dense  infarct  area   in  the
right  hemisphere,  CT angiogram could  not  be  done  as facility  was  not  available
in  our hospital. one  newborn  had  seizure  due  to inborn  error  of  metabolism(1%).
Eight  newborns  had  seizures  for  which   cause  could  not  be  identified(8%).
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ONSET OF SEIZURE
                                                          FIGURE V
TABLE III
ONSET OF SEIZURE
NO OF CASES
NO OF CASES (N=100) %
< 24 HRS 46 46
24 TO 72 HRS 34 34
 >  72 HRS 20
20
4-7 days 8
8-14 days 7
>14 days 5
In  our  study  46  newborns  developed  seizures less than  24  hours(46%), 34
developed  seizures  between  24  to  72 hrs,  20 cases  developed  seizures  after  72
hours  of     life. In our  study  most  of  the  seizures  occurred  within  24  hours  of
life.
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19%
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CORRELATION BETWEEN ONSET OF SEIZURE AND ETIOLOGY
TABLE IV
ETIOLOGY
(n=100)
ONSET OF SEIZURE
< 24 hrs (n=46) 24 – 72 hrs(n=34) >72 hrs (n=20)
Birth asphyxia(33) 18 15 -
Septicemia(27) 3 12 12
Hypoglycemia(20) 12 4 4
Hypocalcemia(8) 4 2 2
IVH(2) 1 - 1
NS(1) 1 - -
IEM(1) 1 - -
Idiopathic(8) 6 1 1
In   our   study   birth   asphyxia   was   the   most   common  cause   of   neonatal
seizure  accounting  33%  of  the  total   cases  of  neonatal   seizure.  Among  the  33
cases  18   cases developed  seizure  within  24  hrs(54%), 15  developed  seizure
between  24 hrs  to  72 hrs(45%). Among  the  27  cases  of  septicaemia  3  babies
developed  seizure  within  24 hrs(20%),  12  developed  seizure  between  24 hrs  to
72 hrs(80%),  and another 12  developed  seizure  after 3rd day. While  most  of  the
hypoglycaemic  seizures  occurred  less  than  24 hrs of  life(60%). 50%  of  the
hypocalcemic  seizures  occurred in  less than  24 hrs  of  life,  while  25%  of  seizures
occurred  between  24 hrs  to  72 hrs  and  remaining  25%  of  the  seizures  occurred
after  72  hrs.   Among   the   intraventricular   haemorrhage   one   developed   seizure
within  24 hrs  of  life, another  developed  seizure  after  72 hrs. Six  of  the  seizures
for  which  cause  could  not  be  identified,  developed  seizure  within  24 hrs.
Neonatal stroke  and  inborn  error  of  metabolism developed  seizure  within  24 hrs.
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TYPE OF SEIZURE
FIGURE VI
TABLE V
TYPE OF SEIZURE
NO OF CASES
N=100 %
Subtle 42 42
Tonic 19 19
Focal 26 26
Myoclonic 5 5
Mixed 8 8
In  our  study  seizures  were  observed  clinically, and  following  five  types
were  documented . 42%  of   seizures were  subtle  seizures, focal  seizures  were  26
cases, tonic  seizures  were  19(19%). Eight  newborns  had  mixed  seizures(8%).
Myoclonic seizures was observed  in  5  newborns(5%).
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CORRELATION BETWEEN TYPE OF SEIZURE AND ETIOLOGY
TABLE VI
Etiology(n)
Type of seizure(n)
Subtle
(42)
Tonic
(19)
Focal
(26) Myoclonic(5)
Mixed
(8)
Birth asphyxia(33) 17 5 6 2 3
Septicaemia(27) 10 5 9 1 2
Hypoglycaemia(20) 9 4 5 0 2
Hypocalcemia(8) 1 5 2 0 0
IVH(2) 0 0 1 1 0
NS(1) 0 0 1 0 0
IEM(1) 1 0 0 0 0
Idiopathic(8) 4 0 2 1 1
Birth asphyxia  accounted   for  majority  of  cases  of   neonatal  seizure, among
them   17   cases   were   subtle   seizures  (51%),  5  cases  were  tonic   seizures(15%),  6
cases were focal  seizures(18%). Out  of  27  cases  septicemia,  most  common  seizure
was   subtle   seizure(37%),   followed  by   focal   seizure(30%).  Out  of   20   cases   of
hypoglycemia,  9  cases  were  subtle  seizure(45%),  5  were  focal  seizure(25%),  4
were  tonic  seizures ( 20%).
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CORRELATION  BETWEEN  TYPE  OF  SEIZURE  AND  ONSET  OF   SEIZURE
TABLE VII
Type of seizure
(n)
Onset of seizure no of cases(n)
<24 hrs (46) 24 – 72 hrs(34) >72 hrs (20)
Subtle (42) 25 13 4
Tonic (19) 10 3 6
Focal (26) 9 13 4
Myoclonic (5) 1 2 2
Mixed (8) 1 3 4
Of  the  46  cases  of  seizures  occurring  less  than  24 hrs,  25  cases  were  subtle
seizures. Out  of  this  25  subtle  seizures  13  cases  occurred  during  24  to  72  hrs
and  4  cases  occurred  after  72  hrs. Out  of  26  focal  seizures  13  cases  occurred
between  24   to   72   hrs,   9  cases   occurred   within   24   hrs.  All    the   5  myoclonic
seizures  occurred  after  24 hrs. Tonic  seizures  mostly  occurred  within 24  hrs
(52%). More  than  50%  of  mixed  type  of  seizures  occurred  after  24hrs
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ABNORMAL  EEG RECORD
TABLE VIII
EEG NO OF CASES
NORMAL 74
ABNORMAL 22
EEG  was taken  for  96  cases  among  which  74  records  were  normal, 22
cases  showed   abnormal   record   mostly   in   the  form   of   abnormal   background
activity. EEG was  not  taken  for  4  cases  as  they  died  during  the  hospital  stay.
FIGURE  VII
PROPORTION  OF  NORMAL  AND  ABNORMAL  EEG  RECORD
NORMAL EEG
ABNORMAL EEG
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CORRELATION BETWEEN ABNORMAL EEG AND ETIOLOGY OF SEIZURE
TABLE IX
Etiology (n)
EEG  (no of cases)
Normal abnormal
Birth asphyxia(33) 22 11
Septicaemia(27) 18 9
Hypoglycemia(20) 20 0
Hypocalcemia(8) 8 0
IVH(2) 2 0
NS(1) 1 0
IEM(1) 1 0
Idiopathic(8) 6 2
Among   33   cases   of    birth   asphyxia   11   cases   had   abnormal   EEG
record(33%),  while  50%   of    septicaemia  cases  had   abnormal  EEG  record,(i.e.  9
cases  among  18  cases  of  neonatal  sepsis). Among  the  8  cases  for  which  cause
could  not  be  identified,  2  cases  had  abnormal  EEG  record(33%). Hypoglycemia
and  hypocalcemia  did  not  show  abnormal  EEG record.
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ETIOLOGY  VS  ABNORMAL  EEG
FIGURE VIII
CORRELATION BETWEEN EEG  AND TYPE OF SEIZURE
TABLE X
Type of seizure
EEG  (No of cases)
normal abnormal
Subtle(42) 34 8
Tonic(19) 17 2
Focal(26) 23 3
Myoclonic(5) 1 4
Mixed(8) 3 5
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Among  the  22  cases  of  abnormal  EEG record  majority  of  cases  were   due  to
subtle  seizures(36%). Out  of  5  cases  of  myoclonic  seizures  4  cases  had  abnormal
EEG record(80%). 62.5% of cases  of  mixed  type  of  seizure  had  abnormal  EEG
record. While  19.04%  of  subtle  seizures,  10.5%  of  tonic  seizures,  11.5%  of  focal
seizures had  abnormal  EEG record.
FIGURE  XI
TYPE  OF  SEIZURE VS  ABNORMAL  EEG RECORD
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RESULTS  AND  ANALYSIS
 Various  parameters  were  assessed  for  developmental  delay,  microcephaly
and  macrocephaly. Among  the  100  cases  enrolled,  4  cases  died  during  the
hospital  stay,  5  cases  were  lost  in  the  follow  up. Of  the  remaining  91  cases
developmental   assessment   was   done,   22  cases   had   only   developmental   delay
(24%),  10   cases   had   isolated   microcephaly(10.9%),  3   cases   had  combination   of
microcephaly  with  developmental  delay (3.2%)  and  2  cases  had  combination  of
macrocephaly   with   developmental   delay.  Statistical   analysis   was   done   for   91
cases  who  had  completed  the  study  using  SPSS  16  software.
TABLE XI
SEX(n)
Developmental delay (n)
p value
absent (69) present (22)
MALE(46) 35 11
0.953
FEMALE(45) 34 11
In  our  study,  out  of  46  male  babies  11  had  developmental  delay(23%), among
the 45  female  babies , 11  had  developmental  delay(24%). No  statistically
significant  difference    was   observed   among   sexes   in   the   occurrence   of
developmental  delay.(p value=0.953)
                                RESULTS  &  ANALYSIS
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TABLE XII
SEX(n)
Isolated
microcephaly(n)
Both
microcephaly&
developmental delay
(n)
Both
macrocephaly&
developmental delay
(n)
present
(10)
absent
(81)
present
(3)
absent
(88)
present
(2)
absent
(89)
MALE(46) 6 40 1 45 2 44
FEMALE(45) 4 41 2 43 0 45
p value 0.52 0.544 0.157
 In  our  study,  13% of  male  babies  had  isolated  microcephaly  and  8%  of
female   babies   had   isolated   microcephaly.  There   was   no    statistically  significant
difference  among  sexes  in  the  occurrence  of  isolated  microcephaly (p value=0.52).
There  was  no  significant   difference  among  sexes  in  the  occurrence  of
‘microcephaly  with  developmental  delay’ (p value=0.544). Occurrence  of
‘macrocephaly   with   developmental   delay’  (2.1%)  did   not   show  any   statistically
significant  difference   among  the  sexes.
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TABLE XIII
MODE OF
DELIVERY(n)
           Developmental delay(n) p value
absent(69) present(22)
Normal vaginal
delivery(50)
40 10 0.36
LSCS(39) 27 12
Forceps delivery(2) 2 0
              Total-91 cases
In our  study  55  cases  were  delivered  by  normal  vaginal  delivery.  2  cases
were  lost in  follow  up, one  had  intraventricular  haemorrhage, another  had  inborn
error   of   metabolism.  One  died  during   the   hospital   stay   due   to   severe   sepsis.
Remaining  50  cases  were  followed  up  and  analyzed. Among  the 41  cases  born
by  LSCS  2  were  lost  in the  follow  up, one had  seizure  due  to  birth  asphyxia and
another  had  seizure  due  to  septicaemia.  So  remaining  39  cases  were  followed
up. Of  the  2  cases  born  by  vacuum  extraction,  one  died  due  to  intraventricular
haemorrhage  and  another  died  due  to  neonatal  stroke. On  analyzing  the  outcome
of   the   remaining   91   cases   there   was   no   statistically   significant   difference
observed  in  the  occurrence of  developmental  delay(p value=0.36)
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TABLE XIV
MODE OF
DELIVERY(n)
Isolated
microcephaly(n)
Both microcephaly&
developmental
delay(n)
Both macrocephaly &
developmental
delay(n)
present
(10)
absent
(81)
present
(3)
absent
(88)
present
(2)
absent
(89)
Normal vaginal
delivery(50)
6 44 2 48 1 49
LSCS(39) 4 35 1 38 1 38
Forceps
delivery(2)
0 2 0 2 0 2
P value 0.852 0.9 0.96
Out   of   50   cases   delivered   by   normal   vaginal   delivery,   6   cases   had
microcephaly;   2   cases   had   ‘microcephaly   with   developmental   delay’   and
‘macrocephaly  with  developmental  delay’  was  noted  in   one  case.  There  was no
statistically   significant   difference   in   the   occurrence   of   isolated   microcephaly(p
value=0.852),  ‘microcephaly  with  developmental delay’(p value=0.9)  and
‘macrocephaly  with  developmental  delay’(p value=0.96)  and  mode  of  delivery.
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TABLE XV
Type of seizure
(n)
Developmental delay(n)
p value
absent(69) present(22)
Subtle (38) 27 11 0.53
Tonic (19) 16 3
Focal (22) 18 4
Myoclonic(4) 2 2
Mixed(8) 6 2
In  our  study,  out  of  22  cases  of  developmental  delay  11  cases  were   due
to    subtle  seizures(50%). On  analysis,  type  of  seizure did  not  have  statistically
significant   difference    in   the   occurrence   of   only    developmental   delay(p
value=0.53).
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TABLE XVI
Type of
seizure (n)
Isolated
microcephaly(n)
Both microcephaly &
developmental
delay(n)
Both macrocephaly&
developmental delay
(n)
PRESENT
(10)
ABSENT
(81)
PRESENT
(3)
ABSENT
(88)
PRESENT
(2)
ABSENT
(89)
subtle (38) 5 33 0 38 0 38
 tonic(19) 2 17 1 18 0 19
 focal(22) 1 21 0 22 2 20
Myoclonic(4) 0 4 2 2 0 4
Mixed(8) 2 6 0 8 0 8
p value 0.522 0.00009 0.170
Type   of   seizure   did   not   have   statistically   significant   difference   in   the
occurrence  of  isolated  microcephaly (p value=0.522). However  out  of  3  cases  of
‘microcephaly  with  developmental  delay’,    2  were  due  to  myoclonic  seizure  and
one  was  due  to  focal  seizure. There  was  significant  difference  observed  with  the
type  of  seizure  in  the  occurrence  of  ‘microcephaly  with  developmental  delay’ (p
value <.05).  Out  of  91  cases  2  cases  had    ‘macrocephaly  with  developmental
delay’, focal  seizure  was  found  in  both  the  cases. Type  of  seizure  did  not  had
statistically   significant   difference   in   the   occurrence   of    ‘macrocephaly   with
developmental  delay’(p value=0.170).
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TABLE XVII
Onset of
seizure(n)
Developmental delay(n)
p value
absent(69) absent(22)
 < 24 hrs(42) 26 16(72%)
0.015* 24-72 hrs(30) 27 3
 >72 hrs(19) 16 3
In  our  study  it  was  found,  there  is  a  relation  between  onset  of seizure
and   developmental  delay. Out  of  91  cases  42  cases  developed  seizures  within  24
hours. Out  of  this  42  cases  72%  of  cases  had  developmental  delay  which  was
statistically  significant (p value=0.015).
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TABLE XVIII
Onset  of
seizure(n)
Isolated
microcephaly(n)
Both microcephaly&
developmental
delay(n)
Both macrocephaly&
developmental
delay(n)
Present
(10)
absent
(81)
present
(3)
absent
(88)
present
(2)
absent
(89)
<24 hrs (42) 5 37 0 42 0 42
 24-72
hrs(30)
3 27 1 29 1 29
>72 hrs (19) 2 17 2 17 1 18
p value 0.966 0.103 0.376
Out  of  91  cases  10  cases  developed   isolated  microcephaly; out  of  this  10
cases  5  cases(50%)  of   microcephaly  was  observed  in  seizures  occurring  less
than  24  hours, but  it  was  not  statistically  significant(p value=0.966). Overall  there
was no  correlation  between  onset  of  seizures  and  microcephaly. Out  of  91  cases
2  cases  developed  ‘macrocephaly  with  developmental  delay’  and  3  cases
developed   ‘microcephaly   with   developmental   delay’.  There   was   no   correlation
between  onset  of  seizure and  the  above  two  parameters.
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TABLE XIX
Etiology of
seizure (n)
Developmental delay(n)
p value
absent(69) present(22)
Birth asphyxia(30) 21 9
0.671
Septicemia (25) 20 5
Hypoglycemia(20) 16 4
Hypocalcemia(8) 7 1
Idiopathic(8) 5 3
Out  of the  22  cases  of  developmental  delay  40%  of  cases  were  due  to
birth  asphyxia. Statistically  it  was  not  significant (p value=0.671). Hence  there  was
no   correlation   between   aetiology   of   seizure   and   developmental   delay   in   our
study.
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TABLE XX
Etiology  of
seizure(n)
Isolated
microcephaly(n)
Both microcephaly
& developmental
delay(n)
Both macrocephaly
& developmental
delay(n)
present
(10)
absent
(81)
present
(3)
absent
(88)
present
(2)
absent
(89)
Birthasphyxia(30 4 26 1 29 0 30
Septicaemia(25) 2 23 1 24 2 23
Hypoglycemia(20 1 19 0 20 0 20
Hypocalcemia(8) 2 6 1 7 0 8
Idiopathic (8) 1 7 0 8 0 8
p value 0.671 0.538 0.249
In  our  study  there  was  no  correlation  between  etiology  of  seizure  and
isolated  microcephaly (p value=0.671), ‘microcephaly  with  developmental  delay’
and  ‘macrocephaly  with  developmental  delay’.
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TABLE XXI
Hypoglycemia(n)
Developmental delay(n)
p value
present(69) absent(22)
<20 mg (6) 4 2
0.78
21-35 mg (7) 6 1
36-45 mg(7) 6 1
>45 mg(71) 53 18
Out   of   91   cases   20   cases   had   hypoglycemia,  out   of   20   cases   of
hypoglycemia  had  developmental  delay  and  it  was  not  statistically  significant.(p
value=0.78)
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TABLE XXII
Hypoglycemia
(n)
Isolated
microcephaly(n)
Both microcephaly
& developmental
delay(n)
Both macrocephaly
& developmental
delay(n)
present
(10)
absent
(81)
present
(3)
absent
(88)
present
(2)
absent
(89)
<20 mg (6) 0 6 0 6 0 6
21- 35 mg(7) 1 6 0 7 0 7
36-45mg (7) 0 7 0 7 0 7
>45 mg(71) 9 62 3 68 2 69
p value 0.59 0.832 0.902
Out  of  20  cases  of  hypoglycemia,  one  case  had  isolated  microcephaly,
there   was   no   cases   of   ‘microcephaly   with   developmental   delay’   or
‘macrocephaly  with  developmental  delay’.
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TABLE XXIII
EEG(n)
Developmental delay(n)
p value
absent(69) present(22)
NORMAL (69) 60 9
<0.001*
ABNORMAL(22) 9 13
EEG   was   taken   for   91   cases   before   discharge   and   22   cases   showed
abnormal  background  activity. 7 cases  had  mild  abnormal  activity  while  15  cases
had  moderate  to  severe  abnormal  background  activity. Among  the  22  cases  with
abnormal  EEG  record  13  had  developmental  delay,  12  with  moderate  to  severe
abnormal  background  activity  and  one  with  mild  abnormal  background  activity.
There   was   statistically   significant   association   with   developmental   delay(p
value<0.001)
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TABLE XXIV
EEG(n)
Isolated
microcephaly(n)
Both microcephaly&
developmental
delay(n)
Both macrocephaly&
developmental
delay(n)
PRESENT
(10)
ABSENT
(81)
PRESENT
(3)
ABSENT
(88)
PRESENT
(2)
ABSENT
(89)
Normal
(69)
8 61 1 68 1 68
Abnormal
(22)
2 20 2 20 1 21
p value 0.741 0.08 0.388
Among  22  cases  with abnormal  EEG  record on follow up to 1year, 2  cases
had  isolated  microcephaly (p value=0.741); 2 cases had  ‘microcephaly with
developmental   delay’(  p  value=0.08)  and    2   cases   had   ‘macrocephaly   with
developmental  delay’ (p value=0.38). On  statistical  analysis  no  significant
difference  was  observed.
Out   of   22   cases  with   abnormal   EEG  record,  on  follow up  for  1year,   18
cases  had  adverse  neurodevelopmental  sequelae; but  4  cases  had  normal  outcome.
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TABLE XXV
AN complication
(n)
Developmental delay(n)
p value
absent(69) present(22)
PIH(13) 10 3
0.998
DM(8) 6 2
Maternal fever(5) 4 1
PROM(7) 5 2
Nocomplication(58) 44 14
          Total-91
In   our   study,   3   newborns   delivered   to   PIH  mother   who  had   neonatal
seizure  had  developmental  delay,  2  among  the  8  born  to  mother  with  diabetes
mellitus  had  developmental  delay. 20%  of  newborn  with  seizure  whose  mother
had  fever  during  perinatal  period  had  developmental  delay. 28%  of  newborn  with
seizure whose  mother  had  premature  rupture  of  membrane  for  >  12  hours  had
developmental   delay.  On   analyzing   there   was   no   statistically   significant
association  between  antenatal  complication  and  developmental  delay(0.998).
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TABLE XXVI
AN
complication
(n)
Isolated
Microcephaly  (n)
Both microcephaly
& developmental
delay (n)
Both
macrocephaly
&developmental
delay (n)
present
(10)
absent
(81)
present
(3)
absent
(88)
present
(2)
absent
(89)
PIH (13) 2 11 0 13 0 13
DM (8) 0 8 0 8 0 8
Maternal
fever(5)
0 5 0 5 1 4
PROM (7) 2 5 0 7 0 7
No
complication(58)
6 52 3 55 1 57
p value 0.393 0.779 0.08
15  %   of   newborn   with   neonatal   seizure  whose   mother   had   PIH   had
isolated microcephaly and  28%  of  newborn  whose  mother  had  premature  rupture
of  membrane  had  isolated microcephaly. 10%  of  newborn  whose  mother  had  no
antenatal  complication  had isolated  microcephaly. There  was  no   statistically
significant   difference    observed   among   isolated  microcephaly   and   antenatal
complication (p value=0.393).
similarly   there   was   no   statistical   significance   between   antenatal
complication  and  ‘microcephaly with developmental delay’ and ‘macrocephaly with
developmental delay’.
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TABLE XXVII
Apgar at 5min(n)
Developmental delay(n)
p value
absent(69) present(22)
 < 3(10) 2 8
<0.001* 3-8(17) 16 1
 >8 hrs(64) 51 13
 Low  5  minute  Apgar  score  was  observed  in  17  newborns,  among  them 9  had
developmental  delay. Among the  9  newborns  8  babies had  Apgar  score  less than
5  at   5  minutes  of  life.  Extended   apgar  score  was  not  available.  On  analysis
there  was  statistically significant  association  between  low  5  minute  Apgar  score
and  developmental  delay (p value< 0.001)
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TABLE XXVIII
Apgar at 5
min (n)
Isolated
microcephaly(n)
Both
microcephaly&
developmental
delay(n)
Both
macrocephaly&
developmental
delay
present
(10)
absent
(81)
present
(3)
absent
(88)
present
(2)
absent
(89)
<3 (10) 1 9 1 9 0 10
 3-8 (17) 3 14 0 17 0 17
>8 (64) 6 58 2 62 2 62
p value 0.62 0.3 0.650
Low  5  minute  apgar  score  was  noted  in  27  cases. 4  out  of  27  cases  with
low  5  minute  Apgar  score  had  isolated microcephaly (p value= 0.62), one  out  27
newborns  with  low  5  minute  Apgar  score  had  ‘microcephaly  with  developmental
delay’  (p  value=  0.3).  Hence   there   was   significant   statistical   association   was
observed   between    low   5  minute   apgar   score   and   ‘microcephaly  with
developmental  delay’.
DISCUSSION
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DISCUSSION
The  current  study  was  undertaken  between  march  2010  and  august
2011. In  this  study  conducted  at  institute  of  social  paediatrics, and  Govt.  RSRM
NICU   we   studied   the   neurodevelopmental   outcome   of   the   babies   who   had
neonatal   seizure   and    analyzed    the   risk   factors   for   the   poor   developmental
outcome.  A  total  of  1856  babies  got  admitted  in  NICU,  among  them  108  term
newborns  had  neonatal  seizure. 4  newborns  with  neonatal  seizure  expired  during
the  hospital  stay.
Sample  size  in  various  studies
              Study                                                               sample size
                Iype  et  al                                                         135
                Tekgul  et  al                                                     89
                Kim  et  al                                                         41
                Brunquell  et  al                                                77
               Arthur  et  al                                                      144
Out  of  108  newborns  91  completed  the  study,  among  the  91  infants
22  had  developmental  delay,  10  had  microcephaly,  3  had  microcephaly  with
developmental   delay   and   2   had   macrocephaly   with   developmental   delay.  On
analyzing   data   out   of   22   infants   with   developmental   delay   50%   were   male
infants  and  50%  were  female  infants, among  10  microcephaly  60%  were  male
and  40%  were  female  infants. There  was  no  predilection for  sexes  as  observed  in
other  studies.
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53%  were  delivered  by  normal  vaginal  delivery  41 %  were  delivered
by  caeserian  section, 4%  were  born  by  forceps  delivery. There  was  no  difference
in outcome  between  the  two  groups. Similar  finding  was  observed  in study
conducted  by  Pisani  et  al.33
Etiology  of seizure
 The  major  cause  of  neonatal   seizure  in  our  study  was  birth  asphyxia
(33%) ,  followed  by  septicemia (27%) ,  hypoglycemia (20%),  and  hypocalcemia
(8%). The  remaining  8%  of  neonatal  seizure  is  idiopathic. Perinatal  asphyxia  was
predominant   cause   in   most   of   the   studies.  In   Tekgul   et   al   study   40%    of
neonatal  seizures  were  due  to    global  cerebral  hypoxic  ischemia,  followed  by
focal   cerebral   ischemia   17%,   transient   metabolic   conditions   were   3%,   and
infection  3% ,  idiopathic  causes  for  neonatal  seizure  were  17%.14 In  a  study  by
Pisani   et   al   cerebral   hypoxic   ischemia,  intraventricular   hemorrhage,   and
meningitis  were  predominant  causes.33  In  a  study  done  by  Arthur  et  al  metabolic
disturbances;  intracerebral  birth  injuries  and perinatal  anoxia,  once  considered
main   causes   for   neonatal   seizures,   were   considerably  less   frequent.40 In   study
conducted  by  Nunes  et   al    most  common  etiology  was  hypoxic  ischemic  en-
cephalopathy  (51%),  followed  by  transient  metabolic  disturbances  (14%),
infection (congenital,  septicemia,  bacterial  meningitis – 9%)  intraventricular
hemorrhage  (6%),   venous  infarct (3%),  inborn  error  of  metabolism (2%)  and
cerebral   dysgenesis   (2%).38  In   a   study   by   Iype   et   al   multiple   causes   were
accounting  for  47.2%  of  cases  of  neonatal  seizure, 40.5%  was  due  to  hypoxic
ischemic  encephalopathy,  hypoglycemia 32.5%.34
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Our  study  showed  similar  etiological  profile  as  other  studies,  except  for  Arthur
et  al.
Type  of  seizure
Subtle   seizure  was the   most  common  type  of  seizure  in  our  study (42%)
followed   by   focal(26%),  tonic  (19%).   Subtle   seizure   was   the   most    common
seizure  observed  in  various  studies. In  studies  by  Mizrahi EM  et  al  and  Volpe JJ
subtle  seizures  were  most  common  seizures  types. In Iype  et  al 60.7%  (82/135)
of  patients had focal clonic seizures, 14.1% (19/135) had subtle seizures, 21.5%
(29/135) had tonic seizures and 3.7% (5/135) had myoclonic seizures.34 In  study  by
Kim  et   al   subtle   seizure   accounted   for   24%,   common  type   being   multifocal
clonic (42%).7 In Tekgul  et   al   common  seizure  type  was  clonic  seizure  (64%),
followed  by  tonic  seizure  (19%).14
Neurodevelopmental  outcome
Developmental  assessment  with  Trivandrum  Development  Screening  Chart
showed  that  out of  91  infants,  at the end of 1year follow up,  adverse neurological
outcome   was  noted  in   37  cases  ; out of this 37 cases of adverse outcome,  22  had
only developmental  delay,  10  had isolated  microcephaly,  3  had  ‘microcephaly
with  developmental  delay’  and  ‘2  had  macrocephaly  with  developmental  delay’.
Remaining 54 cases had normal neurological development.  Adverse neurological
outcome noted in our study was 40%  while other studies also showed  similar adverse
neurological outcome ( ie. between 30%- 50%).
Iype  et  al  study   shows out   of   100   who   came   for   follow   up,   32   had
developmental  delay.  Of   those   with   developmental   delay,   7   of   the   babies
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followed  up  had  post neonatal  epilepsy, 24  had  spasticity, 10  had  abnormal  vision
and  5  had  defective hearing  at    four  months  follow-up. 68  babies  were  normal  at
follow  up.34  In  a study  by  Tekgul  et  al  64  had  favourable  outcome.  and  28%
had  poor  neurological  outcome.(14)
Arthur   et   al   studied   137   term   newborns   with   neonatal   seizure   and
followed  for  4 years. 50%  of  subjects  had  normal  outcome, 20%  died  and  30%
survived  with  serious  neurological  deficit.40  In  a study  by  Grafinkle  et   al,   62
term  neonatal  seizure  subjects  were  followed. A  total  of  23  (37%)  infants  had  a
normal   outcome,   34   (55%)   survived   with   1   or   more  neurodevelopmental
impairments  (23  cerebral  palsy,  28  global  developmental  delay,  15 epilepsy,  with
18  having  combination  of  two  outcome,  and  9  all  three  outcomes),  and  5  (8%)
died.37  In a study  by  Tudehope  et  al,  out  of  156  newborns  with  neonatal  seizure
over  5  years, 43%  had  long-term  disability.39 In  a study  by  Ronen  et  al  45%  had
normal  outcome,  39%  had  impairment.35
Predictors  of  neurodevelopmental  sequelae
Various  factors  play  role  as  predictors  of  adverse  neurological  outcome.
Many   studies   have   found   constellation   of   parameters   to  prognosticate   adverse
outcome. In  our  study  out  of  37  cases  of adverse neurological outcome,  37%  were
due   to   birth   asphyxia,  which  was   statistically   not  significant.   In  our   study   no
statistical  significance  was  found  between  etiology  and  neurodevelopment
outcome. The same conclusion was observed in other studies also. In Iype  et  al  study
statistical   significance could  not  be  established  between  etiology  and  abnormal
neurological   outcome.  Similarly  in  Nunes   et   al   study    no   significant   statistical
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relationship  between  etiology  and  the  neurodevelopmental  outcome  was
observed.38  Contrary to the above two studies,  in  Tekgul  et  al  study   the  statistical
relationship  between  neonatal  seizure  etiology  and  poor  outcome was  found to be
highly  significant.14
Onset  of  seizure:  in  our  study  early onset  of  seizure(seizures  within  24
hours)  showed  poor  prognosis.  Because  out  of  42  cases  of  seizures  manifesting
in  <  24  hrs,  72%  of  subjects  had  developmental  delay,  which  was  statistically
significant. Early  onset  of  seizure  was  poor  prognostic  factor  in  other  studies
also. In  Garfinkle  et al  concluded  in  his  study  that  seizure  occurring  less  than  24
hours  of  life  is  a  major  determinant  of  adverse  neurological outcome.37 Volpe JJ
proposed  that  early  onset  seizure  has  worst  prognosis.8 Tekgul  et  al  in  his  study
had  64%  of  neonatal  seizure  manifesting  in  less  than  24  hours, 20%  between  24
to  72  hours, 16%  of  seizures  occurred  after  72  hours.14
Type   of   seizure:   Type   of   seizure   is   an   independent   risk   factor   for
adverse  neurological  outcome. But  in  our  study,  however  no  statistical  significant
association   was   established   between  type   of   seizure   and   developmental   delay.
While  comparing  other  studies,  some  of  them  have  shown  that  there  was  no  relation
between type of seizure and adverse neurological outcome, while some studies have
shown there was a relation between etiology and outcome.  In  a  study  by  Tekgul  et
al  the  relationship  between  the  type of  neonatal  seizure  and  overall  outcome  did
not  achieve  statistical  significance.14 In  a  study  by  Iype  et al  clonic  seizure  was
common  and  no  statistical  significance  was established  between  seizure  type  and
neurological  outcome.34  But,  in  a  study   by  Garfinkle,   seizure   other   than   focal
clonic  type  had  adverse  outcome37  and  Tudehope  et  al observed that  tonic  seizure
65
had  highest  mortality  and  morbidity.39 Brunquell  et  al aso   observed  in  his  study
that  subtle  seizure  had  abnormal  neurological  outcome.36
EEG   abnormality: In  our  study   22  subjects  had  abnormal  EEG  record.
Among  them  7  had  mild  background  abnormality, 15  had  moderate  to  severe
abnormal  background  activity.  Out of this 22 cases with  abnormal  EEG,
Developmental  delay   was  observed   in   13   subjects   ,   2   cases   had  isolated
microcephaly, 2 cases had ‘microcephaly with developmental delay, and one case had
‘macrocephaly with developmental delay’. While 4 cases had normal  outcome.
In our study,  there  was  significant  association  between  abnormal  EEG  and
development  delay(p value <0.001) which is similar to other studies. Iype  et  al
observed    that   initial   EEG  showing  predominant    spike   waves   was   associated
with abnormal  neurodevelopment  in  50%  (4/8)  of  cases. Sharp  waves  or  a  normal
EEG  were  associated  with  abnormal  development  in  48%  and 22.7%
respectively.34 In  Tekgul  et  al normal  EEG  record  was  observed  in  21 cases, out
of  which  4  had  unfavourable  outcome, 26  EEG  records  were  mild  abnormality,
31  were  moderate  abnormality, 11 were  severe  abnormality.  Association between
abnormal  EEG  with  poor  neurological  outcome  was noted in so  many studies.46,47
Garfinkle  et  al,  Ronen  et  al, Kim et  al, Arthur  et  al,  all  observed  that  abnormal
EEG  record  was  associated  with  poor  long  term  neurological  outcome.37,35,6
Low  5  minute  Apgar  score : In  our  study  out  of  27 newborns  who  had
low  Apgar  score  at  5 minutes  of  life  9  had  developmental  delay(33%).  Among
them  8  subjects  had  score  less  than  3/10. Our  study’s  observation   was  similar
to  the  one  conducted  by  Tudehope  et  al  and   Mellits  et  al.(39,42)
                                                         SUMMARY
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SUMMARY
? A   prospective   study   was   conducted   at   NICU   of   Institute   of   Social
Paediatrics   and   NICU   of   Govt.  RSRM   hospital   to   assess  the
neurodevelopmental  sequelae  in  infants  who  had  neonatal  seizure.
? Out  of  1856  newborn  admission  108 newborn  had  neonatal  seizure, of
which   100   participated   in   the   study,  91  infants   completed   the   study,  4
newborns  expired  during  the  hospital  stay  and  5  were  lost  in   follow-up.
? 55%  were  delivered  by  spontaneous  vaginal  delivery,  41 %  were  born  by
LSCS , 4%  were  delivered  by  forceps  and  2%  by  vacuum  extraction.
? 33%   of   neonatal   seizure   were   due   to   birth   asphyxia,  27  %   due   to
septicemia,
20 % due to  hypoglycemia. In 8%  of  cases  cause  was  unknown.
? Subtle   seizure   was   the   most   common  seizure(42%),   followed  by   focal
seizure(26%), tonic  seizure(19%)   Mixed  type  of  seizure  was  observed  in 8
% of  cases.
? 46%  of  seizure  manifested within  24  hours  of  life, 34%  of  cases  between
24  to  72  hours  of  life, 5%  of  cases  occurred  after  14  days.
? 20%    of   hypoglycemic   seizure   had   developmental   delay   and   level   of
blood  glucose  did  not  have  significant  association  with  the  outcome.
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? EEG  recorded  for  91  cases;   out  of  these  91  cases  22  had   abnormal
background  activity,  of  which  15  had  moderate  to  severe  abnormal
background  activity, 7  had  mild  abnormal  background  activity.
? Family  history  of  seizure was  present  in  4  newborns  among  them  2  had
developmental  delay, though  statistical  significance  was  not  established.
? Regarding  neurodevelopmental  outcome,  37  had  adverse  neurological
outcome.  Out  of  this  37  cases 22  had  only  developmental  delay, 10  cases
had  isolated  microcephaly, 3  cases  had  ‘microcephaly  with  developmental
delay’  and  two  cases  had  macrocephaly.
? The   risk   factors   observed   to   have   adverse   outcome   were   onset   of
seizures(<24 hours), etiology  of  seizures,  low  5  minute  apgar  score  and
abnormal  EEG   record.  .
? 37%  of  adverse  neurological  outcome  was  due to  birth  asphyxia.
? Low  5  minute  apgar  score  was  associated  with  significant  developmental
delay.
? EEG   abnormality   had   significant   developmental   delay.  Out  of    22  cases
with  abnormal  EEG,  Developmental delay  was observed  in  13  subjects  ,  2
cases  had isolated microcephaly, 2 cases had ‘microcephaly with
developmental delay, and one case had ‘macrocephaly with developmental
delay’. While 4 cases had normal  outcome.
                                                    CONCLUSION
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CONCLUSION
From our  study  it  may  be  concluded  that  59%  of  infants  with  neonatal
seizure  had  normal  development, while  41%  had  adverse  neurological  outcome  at
the  end  of  1  year  follow-up. The  risk  factors for  developmental  delay  from  our
study   was   early   onset   of   seizure,  low   5   minute   Apgar   score  and   abnormal
background  EEG.
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ABBREVATIONS
ABG - Arterial  Blood  Gas
CT - Computed  Tomography
DM - Diabetes  Mellitus
EEG - Electro Encephalography
GABA - Gama  Amino  Butyric  Acid
HIE -  Hypoxic  Ischemic  Encephalopathy
HSC - Health  SubCentre
HSV - Herpes  Simplex  Virus
IEM - Inborn Error  of  Metabolism
IVH - Intraventricular  Hemorrhage
MDI - Mental Development  Index
MRI - Magnetic  Resonance  Imaging
NCCP - National  Collaborative  Perinatal  Project
NS - Neonatal  Stroke
PHC - Primary  Health  Centre
PIH - Pregnancy  Induced  Hypertension
PROM - Premature  Rupture  Of  Membrane
TDSC - Trivandrum  Development  Screening  Chart
                                                     ANNEXURES
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PROFORMA
CGC NO:
NAME:
AGE:
SEX:
ADDRESS:
TYPES OF SEIZURES:  subtle/focal/tonic/myoclonic/mixed :S1/S2/S3/S4
Family h/o seizures: yes/no
Family h/o developmental delay: yes/no
ANTENATAL HISTORY :
- h/o fever with rashes: yes/no
- h/o maternal fever during labour/ <2 weeks before labour: yes/no
- h/o maternal GDM: yes/no
- h/o p/v >3 during labour: yes/no
- H/O PIH: yes/no
BIRTH HISTORY:
- mode of delivery : vaginal delivery / LSCS/forceps/vaccum: M1/M2/M3/M4
- apgar score : 1min _/5min_
- baby resuscitated: yes/no
- gestational age:
- birth weight:2.5-3kg /3-4kg />4kg :B1/B2/B3
- liquor: clear/ meconium stained/ foul smelling: L1/L2/L3
- DOB:
- Place of delivery:RSRM/CORP HOSPITAL/PHC/HSC/PRIVATE HOSPITAL :
PD1/PD2/PD3/PD4/PD5
POSTNATAL HISTORY:
- day of onset of seizure: <24 hrs/ 24-72hrs/ >72hrs: D1/D2/D3
- no of episodes of seizure:
- DATE OF ONSET OF SEIZURE:
ix
- DATE OF DEATH:
- Etiology of seizure:
EXAMINATION:
- alert: yes/no
-  active: yes/no
- pallor: yes/no
- febrile : yes/no
- cyanosis: yes/no
- dysmorphic facies: yes/no
- neurocutaneous markers: yes/no
- CVS:
- RS
- P/A:
- CNS:
        AF
        Bulk- wasting: yes/no
        Tone: increased/decreased/normal: T1/T2/T3
        Reflexes : normal/exaggerated/absent: R1/R2/R3
        Power : grades 1/2/3/4/5
-         Plantar :  extensor/ flexor/no response   :P1/P2/P3
 ANTHROPOMETRY:
anthropometry birth 3m 6m 9m 12m
Wt (kg)
Length (cm)
HC (cm)
CC (cm)
INVESTIGATION:
- EEG: normal/abnormal: E1/E2
- CT BRAIN: NORMAL/ ABNORMAL: C1/C2
- Plasma sugar: <20mg/ 21-35mg/ 36-45mg/ >45mg: BS1/BS2/BS3/BS4
- Serum calcium.: LOW/ NORMAL: SC1/SC2
- Lumbar puncture: MENINGITIS/ NO MENINGITIS: LP1/LP2
- blood culture: POSITIVE/NEGATIVE: BC1/BC2
- Urine for metabolic screening: POSITIVE/NEGATIVE: MS1/MS2
- CRP: POSITIVE/NEGATIVE: ½
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KEY  TO  MASTER  CHART
1) Sex of the baby:
   1- male
   2- female
2) Place  of  delivery:
   1- Govt. RSRM Hospital
   2- corporation hospital
   3- PHC
   4- Private  hospital
    5- HSC
3) Mode  of  delivery :
    1- spontaneous vaginal delivery
    2- LSCS
    3- forceps delivery
    4-  vacuum extraction.
4) Type of seizure :
   1- subtle
   2- tonic
   3- focal
   4- myoclonic
   5- mixed
xviii
5) Onset  of seizure:
    1- <24 hours
    2- 24 to 72 hours
    3- >72 hours
6) Etiology:
   1-  birth asphyxia
   2-  septicemia
   3-  hypoglycemia
   4-  hypocalcemia
   5-  IVH
   6-  Neonatal Stroke
   7-  Inborn error of metabolism
   8-  idiopathic
7) Hypoglycemia blood glucose value:
    1-   <20 mg%
    2-    20mg% - 35mg%
    3-    36 mg% to 45 mg%
    4-    >45 mg
8) EEG RECORD:
   1- normal
   2- abnormal
xix
9) Antenatal Complication:
    1- PIH
    2-DM
    3- maternal fever
    4- PROM
    5- no complications
10) Birth weight:
      1-  2.5 kg to 3 kg
      2-  3 kg to 4 kg
      3-   >4kg
11) Family history of seizure:
      1- no
      2-yes
12) Apgar score at 1 minute:
      1 – less than 3
      2 –   score 3-8
      3- more than 8
14) Apgar at 5 minute:
      1 – less than 3
      2-  score 3 to 8
      3 – more than 8
xx
15) Neurodevelopmental delay:
      1- no
      2- yes
16) Microcephaly :
      1- no
      2-yes
17) Microcephaly with developmental delay :
     1- no
     2- yes
18)Macrocephaly:
    1- no
    2- yes
19)Macrocephaly with developmental delay:
     1- no
     2- yes
TRIVANDRUM  DEVELOPMENT  SCREENING CHART
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Name sex
place
of
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ry
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of
delive
ry
type
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seizu
re
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gy
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EE
G
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complicat
ion
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SCO
RE
1 MIN
APG
AR
SCO
RE
5 MIN
neuro
devel
op
ment
al
delay
MICROCEPH
ALY
developeme
ntal
delay+
microcepha
ly
MACROCEPH
ALY
macroceph
aly+
developeme
ntal
delay
B/O SAROJA 1 1 1 1 1 1 4 1 1 1 1 1 1 1 2 1 1 1
B/O RANI 1 1 1 1 2 1 4 1 2 1 1 1 2 1 1 1 1 1
B/O RAMYA 2 2 1 2 2 2 4 1 4 1 2 3 3 1 1 1 1 1
B/O PADMA 1 1 1 5 1 1 4 2 5 1 1 1 3 1 1 1 1 1
B/O KALAIMANI 1 1 2 2 2 2 4 1 4 1 1 3 3 1 1 1 1 1
B/O VIJAYA 2 1 1 2 1 4 4 1 3 1 1 3 3 1 1 1 1 1
B/O
AROKIAMARY 1 1 1 1 1 3 1 1 5 1 1 3 3 2 1 1 1 1
B/O LAVANYA 2 2 2 1 1 4 4 1 3 1 1 3 3 1 1 1 1 1
B/O
THAMIZHSELVI 1 1 1 3 2 1 4 1 5 1 1 1 2 1 1 1 1 1
B/O FATHIMA 2 3 1 1 1 3 3 1 5 1 1 3 3 1 1 1 1 1
B/O
VALLIAMMAL 1 1 2 1 1 1 4 2 4 1 1 1 1 2 1 1 1 1
B/O MUMTAJ 2 1 1 1 2 2 4 1 5 1 1 3 3 1 1 1 1 1
B/O
PUSHPARANI 2 1 1 3 1 3 3 1 5 1 1 3 3 1 1 1 1 1
B/O SELVI 1 2 1 1 2 2 4 1 5 1 2 3 3 1 1 1 1 1
B/O GEETHA 2 1 2 1 3 2 4 1 2 1 1 3 3 1 1 1 1 1
B/O FARZANA 2 4 1 2 1 1 4 1 5 1 1 2 3 1 1 1 1 1
B/O
SAHAYAMARY 1 1 1 3 1 3 3 1 5 1 1 3 3 1 1 1 1 1
B/O SNEHA 1 5 2 2 1 4 4 1 4 1 1 3 3 1 2 1 1 1
B/O NIRMALA 2 1 2 2 2 4 4 1 1 1 1 3 3 1 2 1 1 1
B/O KANIMOZHI 1 1 1 1 1 1 4 2 5 1 1 1 1 2 1 1 1 1
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B/O
TAMHIZHARASI 1 1 2 3 2 2 4 1 1 1 1 3 3 1 1 1 1 1
B/O MANJULA 2 1 2 1 1 3 1 1 2 3 1 3 3 1 1 1 1 1
B/O THENMOZHI 2 1 2 3 3 2 4 1 5 1 1 3 3 1 1 1 1 1
B/O RADHIKA 1 2 2 3 1 3 3 1 5 1 1 3 3 2 1 1 1 1
B/O SIVAPRIYA 1 1 1 1 2 1 4 1 1 1 1 1 1 2 1 1 1 1
B/O
MADHAMMAL 1 1 1 3 1 1 4 1 5 1 1 1 2 1 2 1 1 1
B/O
PRIYADHARSHINI 2 1 1 1 1 3 1 1 5 1 1 3 3 1 1 1 1 1
B/O PRIYA 2 2 2 1 1 2 4 2 5 1 1 3 3 2 1 1 1 1
B/O YASODHA 1 1 3 2 1 1 4 1 5 1 1 1 2 1 1 1 1 1
B/O MUNIAMMA 1 1 2 4 3 2 4 2 5 1 1 3 3 1 1 2 1 1
B/O VALLI 2 1 2 2 3 2 4 1 5 1 1 3 3 1 1 1 1 1
B/O ARULMARY 2 3 1 1 1 1 4 1 4 1 1 1 2 1 2 1 1 1
B/O DEVIKA 1 1 1 1 2 3 2 1 5 1 1 3 3 1 2 1 1 1
B/O
SAMUNDEESWA
RI
1 1 1 3 1 1 4 2 3 1 1 1 1 2 1 1 1 1
B/O KALPANA 1 1 1 1 1 8 4 1 5 1 1 2 3 1 1 1 1 1
B/O SHOBANA 2 1 1 5 2 1 4 2 5 1 1 1 2 1 1 1 1 1
B/O SUMITHRA 2 1 1 3 2 2 4 2 5 1 1 3 3 1 1 1 1 1
B/O JANAKI 2 5 2 1 1 1 4 1 5 1 1 2 2 1 2 1 1 1
B/O JAYAROOPA 2 1 2 1 3 2 4 1 1 1 1 3 3 1 1 1 1 1
B/O AMUDHA 1 1 1 1 1 3 3 1 5 1 1 3 3 1 1 1 1 1
B/O SUJATHA 2 1 2 2 3 2 4 2 5 1 1 3 3 2 1 1 1 1
B/O BANUPRIYA 1 1 1 1 1 1 4 1 5 1 1 1 1 2 1 1 1 1
B/O SNEHA 2 1 1 4 2 1 4 2 5 1 1 1 1 1 1 2 1 1
B/O
SARASWATHI 2 3 2 3 3 2 4 1 1 1 1 3 3 1 1 1 1 1
xiv
B/O SUBASHINI 1 1 2 1 2 2 4 2 5 1 1 3 3 1 2 1 1 1
B/O DEEPA 2 1 1 2 3 2 4 1 5 1 1 3 3 1 1 1 1 1
B/O SIVAGAMI 2 1 2 4 1 8 4 2 1 1 1 3 3 2 1 1 1 1
B/O KAVITHA 1 2 1 1 1 8 4 1 5 1 1 3 3 1 1 1 1 1
B/O SANGEETHA 2 1 2 1 2 2 4 1 5 1 2 3 3 2 1 1 1 1
B/O VIMALATHA 1 1 2 2 1 1 4 1 5 1 1 1 1 1 1 1 1 1
B/O SINDHU 1 1 2 1 2 3 1 1 5 1 1 3 3 1 1 1 1 1
B/O VANAJA 2 1 2 1 1 8 4 2 5 1 1 3 3 2 1 1 1 1
B/O PARVEEN
BANU 1 2 1 3 2 1 4 1 5 1 1 1 2 1 1 1 1 1
B/O CHITHRA 1 1 2 2 1 3 2 1 2 3 1 3 3 2 1 1 1 1
B/O SARALA 1 2 2 3 2 3 3 1 5 1 1 3 3 1 1 1 1 1
B/O MENAKA 2 1 2 5 3 2 4 2 5 1 1 3 3 2 1 1 1 1
B/O RUPA 1 1 1 2 1 1 4 2 5 1 1 1 1 2 1 1 1 1
B/O MALARVIZHI 2 2 3 1 2 1 4 1 5 1 1 1 2 1 1 1 1 1
B/O
POONGOTHAI 1 1 2 3 3 2 4 2 5 1 1 3 3 1 1 1 1 2
B/O
GEETHARANI 2 1 2 1 1 2 4 2 1 1 1 3 3 2 1 1 1 1
B/O
JAYALAKSHMI 1 2 1 2 3 4 4 1 5 1 1 3 3 1 1 1 1 1
B/O SATHYA 2 1 1 1 1 1 4 2 5 1 1 1 1 2 1 1 1 1
B/O
BHUVANESWARI 1 1 2 3 2 4 4 1 1 1 1 3 3 1 1 1 1 1
B/O JOTHI 2 5 1 2 3 4 4 1 5 1 1 3 3 1 1 2 1 1
B/O
VIJAYAPRIYA 1 1 1 1 2 1 4 1 5 1 1 1 2 1 1 1 1 1
B/O VIMALA 2 2 1 4 2 1 4 2 4 1 1 1 1 2 1 1 1 1
B/O
SIVARANJANI 1 1 1 1 1 8 4 1 5 1 1 3 3 1 1 1 1 1
xv
B/O ESWARI 1 1 1 3 2 1 4 1 5 1 1 2 3 1 1 1 1 1
B/O ANURADHA 1 2 2 1 1 3 2 1 5 1 1 3 3 1 1 1 1 1
B/O GAYATHRI 2 1 1 5 3 3 1 1 5 1 1 3 3 2 1 1 1 1
B/O
LOKESHWARI 1 1 1 2 1 3 2 1 2 2 1 3 3 1 1 1 1 1
B/O YASMIN 1 4 1 3 2 2 4 1 3 1 1 3 3 1 1 1 1 2
B/O IRFANA 2 3 1 5 3 8 4 1 5 1 1 3 3 1 2 1 1 1
B/O
JAYABHARATHI 1 1 1 2 1 3 2 1 5 1 1 3 3 1 1 1 1 1
B/O ANBUMALAR 2 2 2 3 2 2 4 1 1 1 1 3 3 1 1 1 1 1
B/O
MOHANAMBAL 2 1 2 2 1 1 4 1 1 1 1 2 2 1 1 1 1 1
B/O POONKODI 2 1 2 3 2 8 4 1 2 1 2 3 3 1 1 1 1 1
B/O KUMARI 2 2 1 2 3 3 2 1 5 1 1 3 3 1 1 1 1 1
B/O RAMA 2 1 1 1 1 1 4 2 5 1 2 1 1 2 1 1 1 1
 B/O SHANTHI 2 1 1 3 2 1 4 1 1 1 1 1 2 1 1 1 1 1
B/O HEPSIBA 2 1 2 1 1 2 4 1 3 1 1 2 3 1 1 1 1 1
B/O RAJESWARI 2 1 2 3 3 3 3 1 2 2 1 3 3 1 1 1 1 1
B/O ARUNA 1 5 1 5 3 2 4 2 5 1 1 3 3 1 2 1 1 1
B/O
GANDHIMATHI 1 2 2 3 1 8 4 1 5 1 1 3 3 2 1 1 1 1
B/O ANITHA 2 1 1 5 2 1 4 2 5 1 1 1 2 1 1 1 1 1
B/O ANANDHI 1 1 1 1 3 3 2 1 5 1 1 3 3 1 1 1 1 1
B/O SASIREKHA  1 1 1 1 1 1 4 1 4 1 1 1 2 1 1 1 1 1
B/O GIRIJA 2 2 1 1 2 1 4 1 5 1 1 1 2 1 1 1 1 1
B/O JANANI 1 1 2 3 1 4 4 1 2 1 1 3 3 2 1 1 1 1
B/O MALARVIZHI 2 1 2 1 3 2 4 1 1 1 1 3 3 1 1 1 1 1
B/O NITHYA 1 1 2 5 2 3 1 1 5 1 2 3 3 1 1 1 1 1
xvi
